WO2020091192A9 - Matured mixed fermentation product of wild-cultivated ginseng in which ginsenoside absorbable in human body and omega-6 fatty acid are increased, and preparation method therefor - Google Patents

Matured mixed fermentation product of wild-cultivated ginseng in which ginsenoside absorbable in human body and omega-6 fatty acid are increased, and preparation method therefor Download PDF

Info

Publication number
WO2020091192A9
WO2020091192A9 PCT/KR2019/008889 KR2019008889W WO2020091192A9 WO 2020091192 A9 WO2020091192 A9 WO 2020091192A9 KR 2019008889 W KR2019008889 W KR 2019008889W WO 2020091192 A9 WO2020091192 A9 WO 2020091192A9
Authority
WO
WIPO (PCT)
Prior art keywords
fermented
wild
ginseng
omega
ginsenoside
Prior art date
Application number
PCT/KR2019/008889
Other languages
French (fr)
Korean (ko)
Other versions
WO2020091192A1 (en
Inventor
조계만
김수철
강상수
박상원
Original Assignee
경남과학기술대학교 산학협력단
경상대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 경남과학기술대학교 산학협력단, 경상대학교산학협력단 filed Critical 경남과학기술대학교 산학협력단
Publication of WO2020091192A1 publication Critical patent/WO2020091192A1/en
Publication of WO2020091192A9 publication Critical patent/WO2020091192A9/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92Oral administration

Definitions

  • the present invention relates to a complex fermentation of wild ginseng matured with enhanced human absorption ginsenoside and omega-6 fatty acids and a method for manufacturing the same, and more specifically, steaming/sealed aging and steaming/open aging of wild ginseng four times alternately After performing, it is prepared by complex fermentation with Lactobacillus brevis BMK484 strain and Lactobacillus plantarium P1201 strain, and is easily absorbed by the human body, ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids ( ⁇ -6 fatty acids; Linoleic acid and arachidonic acid), gaba, phenolics, and the content of the flavonoids is significantly improved fermented sanyangsams fermented complex and a method for producing the same.
  • Ginseng is classified into ginseng ( ⁇ ), wild ginseng ( ⁇ ) or wild ginseng ( ⁇ ) according to the difference between artificial growth and natural growth according to the cultivation environment and morphological differences.
  • wild ginseng belongs to the family Ogapidae and refers to the artificially grown wild ginseng seeds or yusams grown in the mountains by Panax ginseng , a perennial plant, in the wild under the forest in the mountains, and these are called wild ginseng.
  • wild ginseng grown in the wild from ancient times has been hit as the best wild ginseng and is also called camphor ginseng. Most of ginseng has 3-7 outcrops, but wild ginseng is more than that depending on age. The roots of ginseng are thick and short, but wild ginseng is long and thin. Wild ginseng is known to be more effective than cultivated ginseng in terms of various efficacy, but there is not much scientific evidence to support it than ginseng.
  • Ginseng is reported to have various pharmacological effects on body function control by affecting the central nervous system, endocrine system, immune system, and metabolic system, and skin health effects such as whitening, wrinkle improvement, moisturizing and anti-inflammatory effects have also been reported. Such pharmacological effects are known to be due to ginsenosides, which are easily absorbed by the human intestine or skin cells, that is, human absorption.
  • ginsenosides absorbed by the human body include ginsenosides Rg1, Rg3, Rd, Rf, F2, and compound K.
  • Ginsenoside Rg1 improves learning function, anti-fatigue
  • ginsenoside Rf has analgesic action, lipid and oxidation inhibitory action
  • ginsenoside Rg3 inhibits cancer cell metastasis
  • hepatoprotective action inhibits anticancer drug resistance
  • ginsenoside Rd series has been shown to promote the secretion of corticosteroids
  • ginsenoside compound K has anti-cancer, hepatoprotective, skin-protective effects, tumor growth inhibition, antioxidant, and anti-allergic effects.
  • Ginsenoside F2 has been recently known to have an effect of reducing inflammation of atopic skin and suppressing itching.
  • Ginsenoside Compound K (20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol) is a metabolite of ginsenosides. It is known to have excellent absorption in the body and excellent pharmacological activity. Recently, it is known to treat macular degeneration disease. , Neuropathic pain treatment, whitening and wrinkle improvement, etc. effects have also been reported (Registration Patent 10-1539573, Registration Patent 10-1300775, Patent Publication 10-2014-0003198).
  • Fatty acids have a carboxyl group (-COOH) at one end and a methyl group (-CH 3 ) at the other end, and omega-3 ( ⁇ -) depends on the number of carbons from the carbon to which the methyl group is attached ( ⁇ carbon). 3) or omega-6 ( ⁇ -6) fatty acids.
  • Omega-6 fatty acid refers to an unsaturated fatty acid having a double bond on the 6th carbon from the ⁇ carbon, and there are linoleic acid and arachidonic acid.
  • Omega-6 fatty acids are not synthesized in animals, so they are called essential fatty acids, and vegetable oils such as corn oil and peanut oil are known as source foods. Omega-6 fatty acids are effective in lowering blood cholesterol levels.
  • Gabaro Gamma-aminobutyric acid, GABA
  • GABA GABA
  • glutamate decarboxylase GABA
  • glutamic acid GABA
  • CUA glutamate decarboxylase
  • GABA glutamic acid
  • It is also registered as a medicine and is used for the treatment of headache, tinnitus, and decreased motivation due to stroke or cerebral artery sequelae.
  • the human body produces gaba, but as aging progresses due to excessive intake of inappropriate foods or additives, and insufficient intake of vitamins or minerals, the production of gaba in the body is limited. Accordingly, it is necessary to consume foods containing gava.
  • processed wild ginseng products in which the contents of human absorbable ginsenosides, omega-6 fatty acids, gaba, phenolics, and flavonoids are all significantly improved have not been developed yet.
  • the present inventors performed four times alternately steaming and sealed ripening, steaming and open ripening of wild ginseng, and then Lactobacillus brevis BMK484 strain and Lactobacillus plantarium P1201.
  • the contents of human absorbable ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids (linoleic acid and arachidonic acid), gaba, phenolics, and flavonoids were significantly improved.
  • the present invention has been completed.
  • Another object of the present invention is to provide a method for producing a complex fermented fermented mountain ginseng with improved ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids content.
  • Another object of the present invention is to provide a functional food for improving immunity, improving cognitive ability, recovering from fatigue, and eating cosmetics (inner beauty), including the fermented fermented fermented fermented fermented wild ginseng of the present invention.
  • Another object of the present invention is to provide a functional cosmetic for whitening and wrinkle improvement comprising the fermented fermented fermented mountain ginseng of the present invention.
  • the present invention is a complex fermentation of ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and enhanced content of flavonoids including the following steps.
  • the manufacturing method of the present invention may further include the step of drying and powdering the fermented wild wild ginseng from step ii).
  • the wild ginseng is steamed, sealed, and steamed and opened four times in turn.
  • sanyangsam means sanyangsam or sanyang sprout ginseng.
  • 'goat sprout ginseng' refers to wild ginseng outposts including the entire root, leaves and stems of wild ginseng grown in a mountainous area of 500 m or more above sea level between May and July, or seedlings of wild ginseng of 2 years or more in an artificial environment for 90 days. It means that it has been cultivated in hydroponic or soil culture.
  • goat sprout ginseng is an eco-friendly agricultural product that does not use any pesticides during cultivation, and has an advantage over mountain ginseng because it forms a lower price than conventional mountain ginseng due to hydroponics or soil cultivation, year-round production, and shortening the cultivation period.
  • Wild ginseng and wild sprout ginseng can be used as outposts including roots, leaves and whole stems.
  • Steaming can be performed using a steamer such as a conventional steamer, and is performed at 100°C for 30 to 120 minutes. If the steaming time is less than 30 minutes, sufficient steaming does not proceed, so subsequent steps such as ripening may not be smooth and contamination of various bacteria may occur. If it is steamed for more than 120 minutes, the nutrients of wild wild ginseng or wild wild sprout ginseng may be destroyed by long heat treatment.
  • a steamer such as a conventional steamer
  • moisture may be added to the wild ginseng or the wild sprout ginseng so that the moisture content is 40-50%.
  • Sealed aging is carried out for 2-3 days at 70-80°C by placing steamed wild wild ginseng or wild wild sprout ginseng in a sealed aging machine (container).
  • Open maturation is carried out for 2-3 days at 60 ⁇ 70 °C after putting the steamed wild wild ginseng or wild mountain sprout ginseng in the open maturation period.
  • Sealed aging and open aging are performed alternately (alternately), and the order of sealed aging and open aging is irrelevant.
  • wild ginseng is first steamed and first sealed-aged, second steamed and second opened-aged, third steamed, third-sealed, and fourth steamed And it can be carried out by 4th open ripening.
  • the sanyangsam or sanyang sprout ginseng steamed and aged as described above is sufficiently matured and decomposition of the produced physiologically active substances is minimized.
  • the steamed and matured wild ginseng or wild sprout ginseng from step i) is fermented as a complex seed of Lactobacillus brevis BMK484 strain and Lactobacillus plantarium P1201 strain.
  • Lactobacillus brevis BMK484 strain which is one strain constituting the complex seed in the present invention, was isolated/identified by the present inventors from kimchi and deposited with the National Academy of Agricultural Sciences Agricultural Genetic Resource Center (KACC) on December 12, 2016 (trusted No. KACC92157P), the productivity of GABA and the productivity of ginsenoside compound K are excellent (patent application 10-2017-0152033).
  • Lactobacillus plantarium P1201 strain another strain constituting the complex spawn in the present invention, was separated/identified from fermented food by the present inventors and was sent to the National Academy of Agricultural Sciences Agricultural Genetic Resource Center (KACC) on July 19, 2013.
  • KACC National Academy of Agricultural Sciences Agricultural Genetic Resource Center
  • As the deposited strain accesion No. KACC91848P, it has excellent properties of probiotic preparation and productivity of physiologically active substances (Registration Patent No. 10-154418).
  • Lactobacillus brevis BMK484 strain and Lactobacillus plantarium P1201 strain constituting the composite seed of the present invention exhibit a synergistic effect by complementing the fermentation properties.
  • Lactobacillus brevis BMK484 strain is a hetero-lactic acid fermentation lactic acid bacterium, which does not produce enough lactic acid when fermented alone, and Lactobacillus plantarium P1201 strain is fermented with homo-lactic acid fermentation lactic acid bacteria alone.
  • the complex spawn may be added as a separate culture solution for each of the Lactobacillus brevis BMK484 strain and the Lactobacillus plantarium P1201 strain, or may be added as a mixed culture solution mixed culture.
  • the mixing ratio of the two strains may be 3: 1 to 1: 3 (v/v).
  • Fermentation may be performed by inoculating the culture broth of the complex seed into steamed and matured wild ginseng or wild wild ginseng at a concentration of 2 to 10% (v/w) and fermenting for 2 to 7 days at 25 to 40°C.
  • the fermentation rate may be delayed. If it exceeds 10% (v/w), the cell growth rate is high, so the conversion rate of active ginsenosides is low, and the sour taste is excessive. If the fermentation temperature is less than 25°C, the fermentation period is prolonged, causing contamination of various germs. If the fermentation temperature exceeds 40°C, the growth of the strain may be stopped. If the fermentation period is less than 2 days, fermentation is insufficient and menstruation The production of active substances, etc. may be poor, and if it exceeds 7 days, physiologically active substances may be decomposed by overfermentation.
  • the fermented fermented wild mountain ginseng produced by the above steps of the present invention has 1.5 times more ginsenoside Rd2, 8.1 times more ginsenoside Rg3, 11.6 times more ginsenoside F2 than before processing,
  • the content of senoside compound K was increased by more than 12.4 times, the contents of phenolis and flavonoids were also improved by more than 3.6 and 1.4 times, respectively, and the omega-6 fatty acids linoleic acid and arikidonic acid were improved by more than 3.1 and 3.7 times, respectively. It was enhanced, and Gaba was improved by more than 3.1 times (Table 2, Figure 2, Figure 3a, Figure 3b, Table 3).
  • Another object of the present invention is to prepare a complex fermented fermented mountain ginseng with improved ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids contents prepared by the above manufacturing method. to provide.
  • the complex fermented fermented fermented sanyangsam according to the present invention has ginsenoside Rd2 of 2.75 mg/g or more, ginsenoside Rg3 of 2.90 mg/g or more, ginsenoside F2 of 3.61 mg/g or more, and ginsenoside compound K of 6.20 mg/g or more, phenolics 8.48 mg/g or more, flavonoids 2.22 mg/g or more, and omega-6 fatty acids linoleic acid and arikidonic acid, respectively, containing 282.6 mg/100 g or more and 6.6 mg/100 g or more, Gaba contains 100.33 mg/100g or more (Table 2, Figure 2, Figure 3a, Figure 3b, Table 3).
  • the complex fermented fermented mountain ginseng according to the present invention has a remarkably enhanced antioxidant activity (Test Example 4).
  • the present invention is prepared by the above production method, and the contents of ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids are enhanced. Provides functional foods with antioxidant activity, including aged complex fermented products as an active ingredient.
  • the functional food is dried and powdered of the fermented wild ginseng of the present invention as it is, or extracted and used as a food additive, or powder or extract in the form of granules, pills, beverages, jelly, etc. It can be manufactured as a product of
  • the food according to the present invention is useful for improving immunity, improving cognitive ability, recovering from fatigue and eating cosmetics (inner beauty).
  • the present invention is prepared by the above production method, and the contents of ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics and flavonoids are enhanced.
  • Cosmetics according to the present invention are useful for whitening and wrinkle improvement.
  • the fermented wild wild ginseng composite presentation according to the present invention is dried and powdered as it is or extracted and used as an additive in cosmetics for whitening, wrinkle improvement or moisturizing, or manufactured as a product in the form of a mask pack, skin, cream, lotion, etc. Can be.
  • the production method of the present invention produces a processed wild ginseng product with significantly improved ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids content and antioxidant activity compared to conventional methods. Make it.
  • the complex fermented fermented sanyangsam according to the present invention has significantly improved ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids content, and also has excellent antioxidant effects. , It can be used as a material for cosmetics and pharmaceuticals.
  • Functional foods according to the present invention have excellent antioxidant activity, and are useful for improving immunity due to oxidative stress, improving cognitive ability, recovering from fatigue, eating cosmetics and skin care.
  • 1 is an example of a manufacturing process of a composite fermented fermented sanyangsam according to the present invention.
  • FIG. 2 shows the ginsenoside compound HPLC chromatogram of the complex fermentation of sanyangsam according to the present invention.
  • 2A is an HPLC chromatogram of 21 types of ginsenoside standards
  • FIG. 2B is an HPLC chromatogram of a ginsenoside compound of Comparative Example 1
  • FIG. 2C is an HPLC chromatogram of a ginsenoside compound of Comparative Example 2
  • FIG. 2D Is a ginsenoside compound HPLC chromatogram of Example 1
  • 2e is a ginsenoside compound HPLC chromatogram of Example 2.
  • Figure 3 is a graph showing the content of phenolics and flavonoids of fermented wild wild ginseng aging complex according to the present invention.
  • Figure 3a shows the total phenolics content
  • Figure 3b shows the total flavonoids content.
  • Figure 4 is a graph showing the antioxidant activity of the fermentation complex fermented sanyangsam according to the present invention.
  • Figure 4a shows the DPPH radical scavenging activity
  • Figure 4b shows the ABTS radical scavenging activity
  • Figure 4c shows the hydroxyl radical scavenging activity
  • Figure 4d shows the FRAP reducing power.
  • the raw material wild ginseng was prepared as Comparative Example 1, and as Comparative Example 2, 5 kg of wild ginseng was steamed at 100°C for 1 hour, placed in a dry tray (open container), and dried at 65°C for 3 days, and the process was repeated 4 times. Then, after aging for 12 days, a fermented sanyangsam fermentation composition fermented in the same manner as above was prepared.
  • Example 1 Physicochemical properties were measured for Example 1, Example 2, and Comparative Examples 1 and 2.
  • the pH was measured using a pH meter, and the total acidity was calculated in terms of lactic acid by performing the neutralization titration method, and the reducing sugar was performed through the DNS method (Mille, 1953) and converted into glucose. .
  • Example 1 the fermented sanyangsam prepared in accordance with the present invention (Examples 1 and 2) had a lower pH and increased total acidity than Comparative Example 1 (raw sanyangsam), thereby improving preservation and palatability. There was no significant difference in reducing sugar (Table 1).
  • Test example 1 Analysis of ginsenoside content
  • the fermented fermented fermented fermented mountain ginseng of Example 1, the fermented fermented fermented fermented mountain ginseng of Example 2, and the fermented fermentation composition of the raw material mountain ginseng of Comparative Example 1 and the fermented mountain ginseng of Comparative Example 2 were dried at 50 to 55°C for 2 days, respectively. After that, it was pulverized to 100 mesh or less with a grinder and powdered.
  • the powder prepared above was extracted from samginsenoside according to the health functional food analysis method. Specifically, 1 g of each dry powder was accurately taken in a 250 ml Erlenmeyer flask, 20 ml of 70% methanol was added, allowed to stand in a constant temperature water bath at 80° C. for 1 hour, and then cooled. This was centrifuged to take only the supernatant, and this was repeated twice. The supernatant was concentrated under reduced pressure at 60°C, the residue was dissolved in 2 ml of distilled water, filtered through a 0.45 ⁇ m membrane filter, and used as an analysis sample.
  • Ginsenoside compound analysis was performed by high press liquid chromatography (HPLC) by modifying the method described in the functional food analysis method.
  • HPLC high press liquid chromatography
  • TSKgel ODS-100Z was used as the analysis column, and the sample injection amount was 10 ⁇ l, the temperature was 30°C, the measurement wavelength was 203 nm, and the flow rate was 1.0 ml/min.
  • HPLC water was used for solution A and acetonitrile was used for solution B. .
  • ginsenoside Rd2 was about 1.5 times (2.75 mg/g) or more, Ginsenoside Rg3 is about 8.4 times (3.03 mg/g) or more, ginsenoside F2 is about 11.6 times (3.61 mg/g) or more, and ginsenoside compound K is about 12.4 times (6.20 mg/g) or more.
  • Fig. 2d was enhanced.
  • ginsenoside Rd2 was increased by about 2.6 times (4.63 mg/g) or more, and ginsenoside Rg3 was improved by about 8.1 times (2.90 mg/g) or more, especially ginsenoside.
  • Side F2 was significantly improved by about 13.2 times (4.09 mg/g) or more and ginsenoside compound K by about 12.6 times (6.30 mg/g) or more (Fig. 2e).
  • ginsenoside Rg3, ginsenoside F2, and compound K were much more improved compared to the fermented wild ginseng composition of Comparative Example 2.
  • the total phenolics content was compared to Comparative Example 1 (wild ginseng raw material) and Comparative Example 2 (open-aged wild ginseng fermentation composition), the fermented wild wild ginseng complex fermentation according to the present invention (Example 1), respectively It was improved about 3.6 times and 1.5 times, and the complex fermentation of goat sprout ginseng (Example 2) was enhanced by about 3.7 times and 1.4 times, respectively.
  • the total flavonoids content was determined by the Davis variant.
  • the total flavonoids content compared to Comparative Example 1 (wild ginseng raw material) and Comparative Example 2 (open ripened wild ginseng fermentation composition), the wild ginseng aged complex fermented product (Example) according to the present invention, respectively It was improved about 13.1 times and 2.5 times, and the complex fermentation of goat sprout ginseng maturation (Example 2) was improved about 13.2 times and 2.6 times, respectively.
  • Test example 3 Omega 6 fatty acids (linoleic acid and arachidonic acid) and Gaba Content analysis
  • omega 6 fatty acids The content of omega 6 fatty acids was analyzed by gas chromatography (GC), and the content of Gaba was analyzed by an automatic amino acid analyzer.
  • GC gas chromatography
  • GC GC was used for analysis, and after mounting SP-2560 capillary column (100 m ⁇ 0.25 mm, 0.20 ⁇ m, Sigma-Aldrich Co.), nitrogen gas was used as the mobile phase. 20 ⁇ l of the analysis sample was injected to maintain a mobile phase speed of 1 ml/min. At this time, the temperature of the oven was raised to 200°C and then maintained at 230°C for 30 minutes and detected using a fluorescence detector, and the content is shown in Table 3.
  • the fermented wild wild ginseng fermented product (Example 1) according to the present invention was about 3.1 times the amount of linoleic acid and gava, respectively (329.1 mg/100 g: linoleic acid and 100.61). mg/100 g: Gaba) was enhanced, and in particular, arikidonic acid was significantly improved to about 4.1 times (7.4 mg/100 g), and the complex fermented product (Example 2) aged goat sprout ginseng had linoleic acid content (282.6 mg/100 g) ) Was enhanced, and gaba and arikidonic acid were enhanced by about 3.1 and 3.7 times, respectively.
  • Comparative Example 2 comparativative Example 2 (fermented composition of openly aged wild ginseng)
  • the complex fermented product of fermented wild wild ginseng (Examples 1 and 2) according to the present invention showed much improved arachidonic acid and gaba.
  • Antioxidant activity was analyzed by measuring DPPH radical scavenging activity, ABTS radical scavenging activity, hydroxyl radical scavenging activity, and FRAP reducing power.
  • DPPH radical scavenging activity was obtained by adding 0.8 ml of DPPH solution (1.5 ⁇ 10 -4 M) to 0.2 ml of the sample (0.25, 0.5, 1 mg/ml concentration) prepared above, uniformly mixing, and allowing to stand for 30 minutes and then 525 nm. It was carried out by measuring the absorbance at.
  • the negative control of DPPH radical scavenging activity was performed in the same manner using distilled water instead of the sample, and the difference in absorbance was calculated as a percentage (%) by the following equation, and the result is shown in FIG. 4A.
  • Radical scavenging activity (%) [1-(absorbance of negative control ⁇ absorbance of experimental sphere)] ⁇ 100
  • ABTS radical scavenging activity was obtained by mixing 5 ml of 7 mM ABTS reagent and 5 ml of 140 mM K 2 S 2 O 8 (FW 270.3, Sigma 9392) and standing in a dark place for 16 hours to generate cationic radicals, which were then mixed with methanol to 732 nm. In the ABTS solution adjusted so that the absorbance value of the control was 0.7 ⁇ 0.02 was used.
  • the hydroxyl ( ⁇ OH) radical scavenging ability is FeSO 4 .
  • 7H 2 0-EDTA (10 mM) 2 ml and 2-deoxyribose (10 mM) 0.2 ml, H 2 O 2 (10 mM) 0.2 ml and 1.4 ml of each composition of Preparation Example were mixed and reacted at 37° C. for 4 hours, and 1% thiobarbituric acid (TBA) and 2.8% trichloroaceric acid (TCA) were added to the mixture.
  • TSA thiobarbituric acid
  • TCA trichloroaceric acid
  • FRAP Fanric reducing antioxidant power
  • the reducing power analysis is a method of measuring the reducing power of a compound, and is a method of measuring the power to reduce Fe 3 + to Fe 2 + .
  • FeIII-TPTZ ferric tripyridyl triazine
  • blue FeII-TPTZ ferrous tripyridyl triazine
  • reaction solution was 30 mM acetate buffer (pH 3.6), 10 mM 2,4,6-tripyridyl-s-triazine dissolved in 40 mM hydrochloric acid (TPTZ, T1253, C 18 H 12 N 6 , MW312.33) and 20 mM FeCl 3 (F7134, MW 162.20, in DW) were prepared, and acetate buffer, TPTZ solution and FeCl 3 solution were mixed in 10:1:1 (v/v/v) at 37°C. It was allowed to pre-react for 15 minutes.
  • TPTZ 2,4,6-tripyridyl-s-triazine dissolved in 40 mM hydrochloric acid
  • FeCl 3 FeCl 3
  • the fermented wild wild ginseng complex fermentation according to the present invention (Example 1) and goat sprouts
  • the three-aged fermentation complex (Example 2) significantly improved DPPH radical scavenging activity, ABTS radical scavenging activity, hydroxyl radical scavenging activity, and FRAP reducing power.
  • the examples 1 and 2 were The DPPH radical scavenging activity was 90.66% and 89.92%, respectively, the ABTS radical scavenging activity was 89.77% and 94.37%, respectively, the hydroxyl radical scavenging activity was 64.57% and 67.72%, respectively, and the FRAP reducing power was very high at 1.752 and 1.859, respectively.
  • the fermented fermented fermented sanyangsam or sanyang sprout ginseng according to the present invention remarkably enhances its antioxidant activity and thus is useful as a material for functional foods or cosmetics.

Abstract

Disclosed are a matured mixed fermentation product of wild-cultivated ginseng in which the amounts of ginsenosides Rd2, Rg3, F2, and compound K that are easily absorbed by the human body, omega-6 fatty acids (ω-6 fatty acids: linoleic acid and arachidonic acid), GABA, phenolics, and flavonoids are significantly increased, and a preparation method therefor. The matured mixed fermentation product of wild-cultivated ginseng according to the present invention has significantly increased amounts of ginsenosides Rd2, Rg3, F2, and compound K, omega-6 fatty acids, GABA, phenolics, and flavonoids, and has excellent antioxidant effects, and thus can be used as a material for functional foods and pharmaceuticals. Functional foods and cosmetics according to the present invention have excellent antioxidant activity, thus being useful for improving lowered immunity due to oxidative stress caused by radicals or the like, improving cognitive ability, overcoming fatigue, and for use in oral cosmetics and skin care.

Description

인체 흡수형 진세노사이드 및 오메가-6 지방산이 증진된 산양삼 숙성 복합발효물 및 그 제조방법Fermented wild ginseng matured complex fermented product with enhanced human absorption-type ginsenoside and omega-6 fatty acid and its manufacturing method
본 발명은 인체 흡수형 진세노사이드 및 오메가-6 지방산이 증진된 산양삼 숙성 복합발효물 및 그 제조방법에 관한 것으로, 더 상세하게는 산양삼을 증숙/밀폐 숙성과 증숙/개방 숙성을 교대로 4회 수행한 후에 락토바실러스 브레비스 BMK484 균주와 락토바실러스 플란타륨 P1201 균주로 복합발효하여 제조되어, 인체 흡수가 용이한 진세노사이드 Rd2, Rg3, F2와 컴파운드 케이, 오메가-6 지방산(ω-6 지방산; 리놀레산과 아라키돈산), 가바, 페놀릭스, 및 플라보노이드스 함량이 현저히 증진된 산양삼 숙성 복합발효물 및 그 제조방법에 관한 것이다.The present invention relates to a complex fermentation of wild ginseng matured with enhanced human absorption ginsenoside and omega-6 fatty acids and a method for manufacturing the same, and more specifically, steaming/sealed aging and steaming/open aging of wild ginseng four times alternately After performing, it is prepared by complex fermentation with Lactobacillus brevis BMK484 strain and Lactobacillus plantarium P1201 strain, and is easily absorbed by the human body, ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids (ω-6 fatty acids; Linoleic acid and arachidonic acid), gaba, phenolics, and the content of the flavonoids is significantly improved fermented sanyangsams fermented complex and a method for producing the same.
삼( Ginseng)은 재배환경에 따른 인위적인 성장과 자연적인 성장의 차이와 형태학적 차이 등에 따라 인삼(人蔘), 산삼(山蔘) 또는 산양삼(山羊蔘)으로 구분한다. 특히 산양삼은 오가피과에 속하며 다년생 초목인 인삼( Panax ginseng)이 산간의 삼림하의 야생상태에서 자연적으로 성장한 산삼의 씨앗이나 유삼을 인위적으로 산에서 재배한 것을 말하며 이들을 산양삼이라 한다. 또한 예로부터 야생에서 자생한 산삼은 최고의 산삼으로 쳤으며 장뇌삼이라고도 불린다. 인삼의 경우에는 대부분 노두(머리 부분)가 3-7개 정도이나 산양삼은 연령에 따라 그 이상인 것이 많으며 인삼의 뿌리는 굵고 짧으나 산양삼은 길고 가늘다. 산양삼은 여러 효능면에서 재배 인삼보다 효과가 더 높은 것으로 알려져 있으나 이를 뒷받침 할 수 있는 과학적 근거가 인삼에 비해 그리 많지는 않은 것은 현 실정이다. Ginseng is classified into ginseng (人蔘), wild ginseng (山蔘) or wild ginseng (山羊蔘) according to the difference between artificial growth and natural growth according to the cultivation environment and morphological differences. In particular, wild ginseng belongs to the family Ogapidae and refers to the artificially grown wild ginseng seeds or yusams grown in the mountains by Panax ginseng , a perennial plant, in the wild under the forest in the mountains, and these are called wild ginseng. In addition, wild ginseng grown in the wild from ancient times has been hit as the best wild ginseng and is also called camphor ginseng. Most of ginseng has 3-7 outcrops, but wild ginseng is more than that depending on age. The roots of ginseng are thick and short, but wild ginseng is long and thin. Wild ginseng is known to be more effective than cultivated ginseng in terms of various efficacy, but there is not much scientific evidence to support it than ginseng.
삼은 중추신경계를 비롯하여 내분비계, 면역계, 대사계 등에 영향을 미쳐 신체기능 조절에 다양한 약리효과를 나타낸다고 보고되어 있으며, 또한 미백, 주름개선, 보습 및 항염증 효과 등의 피부건강 효과 역시 보고되어 있다. 이와 같은 약리효과는 특히 인체 장내 혹은 피부 세포에서 흡수가 용이한 즉, 인체 흡수형 진세노사이드에 기인하는 것으로 알려져 있다. Ginseng is reported to have various pharmacological effects on body function control by affecting the central nervous system, endocrine system, immune system, and metabolic system, and skin health effects such as whitening, wrinkle improvement, moisturizing and anti-inflammatory effects have also been reported. Such pharmacological effects are known to be due to ginsenosides, which are easily absorbed by the human intestine or skin cells, that is, human absorption.
인체 흡수형 진세노사이드로는 진세노사이드 Rg1, Rg3, Rd, Rf, F2, 컴파운드 케이(compound K) 등이 있다. 진세노사이드 Rg1은 학습기능 개선, 항피로 작용, 진세노사이드 Rf는 뇌신경세포 진통작용, 지질과 산화 억제작용, 진세노사이드 Rg3는 암세포 전이억제, 간보호 작용, 항암제 내성억제 작용, 진세노사이드 Rd 계열은 부신피질 호르몬 분비 촉진 작용, 진세노사이드 컴파운드 케이는 항암작용, 간보호 작용, 피부보호 작용, 종양증식억제 작용, 항산화 작용, 항알레르기 작용이 밝혀져 있다. 진세노사이드 F2는 아토피성 피부의 염증을 가라앉히고 가려움증을 억제시키는 효과가 최근에 알려져 있다. 진세노사이드 컴파운드 케이 (20-O-beta-D-glucopyranosyl-20(S)- protopanaxadiol)는 진세노사이드 대사체로서 특히 체내 흡수율이 탁월하고 약리학적 활성도 우수한 것으로 알려져 있으며, 최근에는 황반변성질환 치료, 신경변증성 통증 치료, 미백과 주름개선 등의 효과 역시 보고되어 있다 (등록특허 10-1539573, 등록특허10-1300775, 공개특허 10-2014-0003198).Examples of ginsenosides absorbed by the human body include ginsenosides Rg1, Rg3, Rd, Rf, F2, and compound K. Ginsenoside Rg1 improves learning function, anti-fatigue, ginsenoside Rf has analgesic action, lipid and oxidation inhibitory action, ginsenoside Rg3 inhibits cancer cell metastasis, hepatoprotective action, inhibits anticancer drug resistance, ginsenoside Rd series has been shown to promote the secretion of corticosteroids, and ginsenoside compound K has anti-cancer, hepatoprotective, skin-protective effects, tumor growth inhibition, antioxidant, and anti-allergic effects. Ginsenoside F2 has been recently known to have an effect of reducing inflammation of atopic skin and suppressing itching. Ginsenoside Compound K (20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol) is a metabolite of ginsenosides. It is known to have excellent absorption in the body and excellent pharmacological activity. Recently, it is known to treat macular degeneration disease. , Neuropathic pain treatment, whitening and wrinkle improvement, etc. effects have also been reported (Registration Patent 10-1539573, Registration Patent 10-1300775, Patent Publication 10-2014-0003198).
그러나 이들 인체 흡수형 진세노사이드는 인삼 자체에는 거의 함유되어 있지 않아, 이를 해결하고자 효소를 이용하여 인삼에 포함된 진세노사이드를 인체 흡수형으로 전환하는 기술들이 몇몇 개발되어 있으나, 이들 기술은 비용이 높거나 인체 흡수형 진세노사이드의 증진률이 낮은 문제를 내포하고 있어서, 여전히 인체 흡수형 진세노사이드가 증진된 산양삼 가공품의 개발이 요구되고 있는 실정이다. However, since these human-absorbable ginsenosides are hardly contained in ginseng itself, several technologies have been developed to convert ginsenosides contained in ginseng into human-absorbable types using enzymes to solve this problem. Since this high or low enhancement rate of human-absorbable ginsenoside is implicated, there is still a demand for the development of processed sanyang ginseng products with enhanced human-absorbable ginsenoside.
지방산은 한쪽 말단이 카복실기 (-COOH)이고 다른 쪽 말단이 메틸기 (-CH 3)인데, 메틸기가 붙어 있는 탄소 (ω 탄소)로부터 몇 번째 탄소에 이중결합이 있는가에 따라 오메가-3 (ω-3) 또는 오메가-6 (ω-6) 지방산으로 나눌 수 있다. 오메가-6 지방산은 ω 탄소로부터 6번째 탄소에 이중결합이 있는 불포화지방산을 말하며, 리놀레산 (linoleic acid)과 아라키돈산 (arachidonic acid)이 있다. 오메가-6 지방산은 동물체 내에서 합성되지 않으므로 필수지방산이라 하며, 식물성 기름인 옥수수기름과 낙화생기름이 급원식품으로 알려져 있다. 오메가-6 지방산은 혈액 콜레스테롤 양을 저하시키는 데 효과가 있다. Fatty acids have a carboxyl group (-COOH) at one end and a methyl group (-CH 3 ) at the other end, and omega-3 (ω-) depends on the number of carbons from the carbon to which the methyl group is attached (ω carbon). 3) or omega-6 (ω-6) fatty acids. Omega-6 fatty acid refers to an unsaturated fatty acid having a double bond on the 6th carbon from the ω carbon, and there are linoleic acid and arachidonic acid. Omega-6 fatty acids are not synthesized in animals, so they are called essential fatty acids, and vegetable oils such as corn oil and peanut oil are known as source foods. Omega-6 fatty acids are effective in lowering blood cholesterol levels.
가바 (Gamma-aminobutyric acid, GABA)는 탄소 4개로 구성되어진 비-단백성 아미노산으로 글루타메이트 디카르복실라제(GADase)에 의해 글루탐산(glutamic acid; GA)으로부터 탈탄산 반응과 함께 이산화탄소가 방출됨으로써 가바로 전환되어진다. 가바는 뇌에서 신경전달물질로서의 역할뿐 아니라 뇌기능 촉진, 정신안정작용, 혈압저하작용, 이뇨작용, 간 기능 개선 작용, 비만 방지 작용, 알코올대사 촉진작용 및 소취작용 등 매우 다양한 생리기능을 갖고, 또한 의약품으로 등록되어 뇌졸중 또는 뇌동맥 후유증에 의한 두통, 이명 및 의욕저하 등의 치료에 사용되고 있다. 보통 인체에서 가바를 생성하지만 부적절한 식품 또는 첨가물의 과잉섭취, 비타민이나 무기질류의 섭취 부족에 의해 노화가 진행되면서부터 체내의 가바 생성에는 한계가 오게 된다. 이에 따라서 가바가 포함된 식품의 섭취가 필요로 한다. Gabaro (Gamma-aminobutyric acid, GABA) is a non-proteinaceous amino acid composed of four carbons. By glutamate decarboxylase (GADase) from glutamic acid (GA), carbon dioxide is released along with decarboxylation reactions and carbon dioxide is released. Is converted. Gaba not only plays a role as a neurotransmitter in the brain, but also has a wide variety of physiological functions such as promoting brain function, mental stability, lowering blood pressure, diuretic, improving liver function, preventing obesity, promoting alcohol metabolism, and deodorizing. It is also registered as a medicine and is used for the treatment of headache, tinnitus, and decreased motivation due to stroke or cerebral artery sequelae. Normally, the human body produces gaba, but as aging progresses due to excessive intake of inappropriate foods or additives, and insufficient intake of vitamins or minerals, the production of gaba in the body is limited. Accordingly, it is necessary to consume foods containing gava.
산양삼 가공품과 관련하여서는 인체 흡수형 진세노사이드, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 모두 현저히 증진된 산양삼 가공품은 아직까지 개발된바 없다.Regarding processed wild ginseng products, processed wild wild ginseng products in which the contents of human absorbable ginsenosides, omega-6 fatty acids, gaba, phenolics, and flavonoids are all significantly improved have not been developed yet.
이에 본 발명자들은 종래 기술의 요구에 부응하기 위한 연구를 지속한 결과, 산양삼을 증숙 및 밀폐 숙성과, 증숙 및 개방 숙성을 교대로 4회 수행한 후 락토바실러스 브레비스 BMK484 균주와 락토바실러스 플란타륨 P1201 균주로 복합발효하여 가공한 경우, 인체 흡수형 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산 (리놀레산과 아라키돈산), 가바, 페놀릭스, 및 플라보노이드스 함량이 현저히 증진됨을 확인하고 본 발명을 완성하게 되었다.Accordingly, as a result of continuing research to meet the requirements of the prior art, the present inventors performed four times alternately steaming and sealed ripening, steaming and open ripening of wild ginseng, and then Lactobacillus brevis BMK484 strain and Lactobacillus plantarium P1201. In the case of complex fermentation and processing as a strain, it was confirmed that the contents of human absorbable ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids (linoleic acid and arachidonic acid), gaba, phenolics, and flavonoids were significantly improved. The present invention has been completed.
따라서 본 발명의 목적은 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 증진된 산양삼 숙성 복합발효물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a complex fermented fermented sanyangsam with improved ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids content.
본 발명의 또 다른 목적은 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 증진된 산양삼 숙성 복합발효물의 제조방법을 제공하는 것이다.Another object of the present invention is to provide a method for producing a complex fermented fermented mountain ginseng with improved ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids content.
본 발명의 또 다른 목적은 본 발명의 산양삼 숙성 복합발효물을 포함하는 면역력 저하 개선, 인지능력 개선, 피로회복 및 먹는 화장품(이너뷰티)용 기능성식품을 제공하는 것이다.Another object of the present invention is to provide a functional food for improving immunity, improving cognitive ability, recovering from fatigue, and eating cosmetics (inner beauty), including the fermented fermented fermented fermented fermented wild ginseng of the present invention.
본 발명의 또 다른 목적은 본 발명의 산양삼 숙성 복합발효물을 포함하는 미백 및 주름개선용 기능성 화장품을 제공하는 것이다.Another object of the present invention is to provide a functional cosmetic for whitening and wrinkle improvement comprising the fermented fermented fermented mountain ginseng of the present invention.
상기 목적을 달성하기 위하여, 본 발명은 하기와 같은 단계들을 포함하는 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 증진된 산양삼 숙성 복합발효물의 제조방법을 제공한다:In order to achieve the above object, the present invention is a complex fermentation of ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and enhanced content of flavonoids including the following steps. Provides a method of making water:
i) 산양삼을 증숙 및 밀폐 숙성과 증숙 및 개방 숙성을 교대로 4회 수행하는 단계; 및 i) performing steaming and sealed ripening of wild ginseng and performing steaming and open ripening alternately four times; And
ii) 락토바실러스 브레비스 BMK484 균주와 락토바실러스 플란타륨 P1201 균주의 복합 종균으로 발효하는 단계.ii) Fermenting with a complex seed of Lactobacillus brevis BMK484 strain and Lactobacillus plantarium P1201 strain.
본 발명의 제조방법은, 추가로, 단계 ii)로부터의 산양삼 숙성 복합발효물을 건조시켜 분말화하는 단계를 포함할 수 있다.The manufacturing method of the present invention may further include the step of drying and powdering the fermented wild wild ginseng from step ii).
단계 i): Step i): 산양삼Sanyangsam 증숙Steaming 및 숙성 And ripening
산양삼을 증숙 및 밀폐 숙성과 증숙 및 개방 숙성을 교대로 4회 수행한다. The wild ginseng is steamed, sealed, and steamed and opened four times in turn.
본 발명에서 '산양삼'은 산양삼 또는 산양새싹삼을 의미한다. In the present invention, "sanyangsam" means sanyangsam or sanyang sprout ginseng.
본 발명에서 '산양새싹삼'은 해발 500m 이상의 산지에서 재배된 3년근 이상의 5월 ~ 7월 사이 산양삼의 뿌리, 잎과 줄기 전체를 포함한 산양삼 전초 혹은 2년근 이상 산양삼의 묘삼을 인공 환경에서 90일 이내로 수경 혹은 토경 재배한 것를 의미한다. 한편 산양새싹삼은 재배 동안에는 농약이 전혀 사용되지 않은 친환경 농산물로 수경 혹은 토경 재배, 연중생산 가능 및 재배 기간의 단축으로 인해 종래에 이용되는 산양삼보다 낮은 가격을 형성하고 있어 산양삼 보다 장점이 있다. In the present invention,'goat sprout ginseng' refers to wild ginseng outposts including the entire root, leaves and stems of wild ginseng grown in a mountainous area of 500 m or more above sea level between May and July, or seedlings of wild ginseng of 2 years or more in an artificial environment for 90 days. It means that it has been cultivated in hydroponic or soil culture. On the other hand, goat sprout ginseng is an eco-friendly agricultural product that does not use any pesticides during cultivation, and has an advantage over mountain ginseng because it forms a lower price than conventional mountain ginseng due to hydroponics or soil cultivation, year-round production, and shortening the cultivation period.
본 발명에서 산양새싹삼은 자연 환경에서 재배된 5월에 수확한 산양새싹삼 혹은 인공 환경에서 30일 배양된 산양새싹삼을 사용하는 것이 바람직하며, 더 바람직하게는 인공 환경에서 30일 배양된 산양새싹삼을 사용한다. In the present invention, it is preferable to use the goat sprout ginseng harvested in May cultivated in a natural environment or the goat sprout ginseng grown for 30 days in an artificial environment, and more preferably, the goat sprouts cultured for 30 days in an artificial environment. Use hemp.
산양삼과 산양새싹삼은 뿌리, 잎, 줄기 전체를 포함한 전초로 사용될 수 있다. Wild ginseng and wild sprout ginseng can be used as outposts including roots, leaves and whole stems.
산양삼 또는 산양새싹삼을 흐르는 물에 3회 세척하고 물기를 제거한 후 증숙한다. Wash wild wild ginseng or wild wild sprout ginseng 3 times with running water, remove moisture, and steam.
증숙은 통상의 찜기와 같은 증숙기를 사용하여 수행할 수 있으며, 100℃에서 30 ~ 120분간 수행한다. 증숙 시간이 30분 미만인 경우 충분한 증숙이 진행되지 않아 숙성과 같은 후속 단계가 원활하지 않을 수 있고 잡균의 오염이 발생될 수 있다. 120분 초과하여 증숙될 경우는 오랜 열처리로 산양삼 또는 산양새싹삼의 영양성분이 파괴될 수 있다.Steaming can be performed using a steamer such as a conventional steamer, and is performed at 100°C for 30 to 120 minutes. If the steaming time is less than 30 minutes, sufficient steaming does not proceed, so subsequent steps such as ripening may not be smooth and contamination of various bacteria may occur. If it is steamed for more than 120 minutes, the nutrients of wild wild ginseng or wild wild sprout ginseng may be destroyed by long heat treatment.
증숙시, 필요에 따라서, 수분 함량 40 ~ 50%가 되도록 산양삼 또는 산양새싹삼에 수분을 첨가할 수 있다. During steaming, if necessary, moisture may be added to the wild ginseng or the wild sprout ginseng so that the moisture content is 40-50%.
밀폐 숙성은 증숙된 산양삼 또는 산양새싹삼을 밀폐형 숙성기(용기)에 담고 70 ∼ 80℃에서 2 ∼ 3일간 숙성을 수행한다.Sealed aging is carried out for 2-3 days at 70-80℃ by placing steamed wild wild ginseng or wild wild sprout ginseng in a sealed aging machine (container).
개방 숙성은 증숙된 산양삼 또는 산양새싹삼을 개방형 숙성기에 담은 후 60 ∼ 70℃에서 2 ∼ 3일간 숙성을 수행한다.Open maturation is carried out for 2-3 days at 60 ~ 70 ℃ after putting the steamed wild wild ginseng or wild mountain sprout ginseng in the open maturation period.
밀폐 숙성과 개방 숙성은 번갈아(교대로) 수행되며 밀폐 숙성과 개방 숙성의 순서는 상관이 없다. Sealed aging and open aging are performed alternately (alternately), and the order of sealed aging and open aging is irrelevant.
일예로서 하기 실시예(제조예)에 예시된 바와 같이, 산양삼을 1차 증숙하고 1차 밀폐 숙성하고, 2차 증숙하고 2차 개방 숙성하고, 3차 증숙하고 3차 밀폐 숙성하고, 4차 증숙하고 4차 개방 숙성하여 수행할 수 있다. As an example, as exemplified in the following Examples (Preparation Example), wild ginseng is first steamed and first sealed-aged, second steamed and second opened-aged, third steamed, third-sealed, and fourth steamed And it can be carried out by 4th open ripening.
상기와 같이 증숙 및 숙성된 산양삼 또는 산양새싹삼은 숙성이 충분히 되고 생산된 생리활성물질의 분해가 최소화된다. The sanyangsam or sanyang sprout ginseng steamed and aged as described above is sufficiently matured and decomposition of the produced physiologically active substances is minimized.
단계 ii) 복합발효Step ii) Complex fermentation
상기 단계 i)로부터의 증숙 및 숙성된 산양삼 또는 산양새싹삼을 락토바실러스 브레비스 BMK484 균주와 락토바실러스 플란타륨 P1201 균주의 복합 종균으로 발효한다.The steamed and matured wild ginseng or wild sprout ginseng from step i) is fermented as a complex seed of Lactobacillus brevis BMK484 strain and Lactobacillus plantarium P1201 strain.
본 발명에서 복합 종균을 구성하는 하나의 균주인 락토바실러스 브레비스 BMK484 균주는 본 발명자들이 김치로부터 분리/동정하여 국립농업과학원 농업유전자원센터(KACC)에 2016년 12월 12일에 기탁한 균주(수탁번호 KACC92157P)로, 가바(GABA)의 생산성 및 진세노사이드 컴파운드 케이(compound K) 생산성이 탁월하다 (특허출원 10-2017-0152033).Lactobacillus brevis BMK484 strain, which is one strain constituting the complex seed in the present invention, was isolated/identified by the present inventors from kimchi and deposited with the National Academy of Agricultural Sciences Agricultural Genetic Resource Center (KACC) on December 12, 2016 (trusted No. KACC92157P), the productivity of GABA and the productivity of ginsenoside compound K are excellent (patent application 10-2017-0152033).
본 발명에서 복합종균을 구성하는 또 다른 하나의 균주인 락토바실러스 플란타륨 P1201 균주는 본 발명자들이 발효식품으로부터 분리/동정하여 국립농업과학원 농업유전자원센터(KACC)에 2013년 7월 19일에 기탁한 균주(수탁번호 KACC91848P)로서, 생균제제능이 우수하고 생리활성물질 생산성이 우수한 특성을 갖는다 (등록특허 10-154418호).Lactobacillus plantarium P1201 strain, another strain constituting the complex spawn in the present invention, was separated/identified from fermented food by the present inventors and was sent to the National Academy of Agricultural Sciences Agricultural Genetic Resource Center (KACC) on July 19, 2013. As the deposited strain (Accession No. KACC91848P), it has excellent properties of probiotic preparation and productivity of physiologically active substances (Registration Patent No. 10-154418).
본 발명의 복합종균을 구성하는 락토바실러스 브레비스 BMK484 균주와 락토바실러스 플란타륨 P1201 균주는 발효 특성이 상호 보완되어 상승작용을 나타낸다. 락토바실러스 브레비스 BMK484 균주는 이형유산발효 (hetero-lactic acid fermentation) 유산균으로 단독 발효 시 유산 생성이 충분하지 않고, 락토바실러스 플란타륨 P1201 균주는 동형유산발효(homo-lactic acid fermentation) 유산균으로 단독 발효 시 유산이 과다하게 생성되는데, 놀랍게도 산양삼 또는 산양새싹삼 전초를 이들 두 가지 종균을 함께 사용하여 복합발효시 양 균주의 발효 특성이 상호 보완되고 인체 흡수형 진세노사이드, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 현저히 증진되었다 (시험예 1~4).The Lactobacillus brevis BMK484 strain and Lactobacillus plantarium P1201 strain constituting the composite seed of the present invention exhibit a synergistic effect by complementing the fermentation properties. Lactobacillus brevis BMK484 strain is a hetero-lactic acid fermentation lactic acid bacterium, which does not produce enough lactic acid when fermented alone, and Lactobacillus plantarium P1201 strain is fermented with homo-lactic acid fermentation lactic acid bacteria alone. When lactic acid is generated excessively, surprisingly, the fermentation characteristics of both strains are complemented by the use of these two seed germs together, surprisingly, and human absorption-type ginsenosides, omega-6 fatty acids, gaba, The content of phenolics and flavonoids was remarkably improved (Test Examples 1 to 4).
본 발명에서 복합종균은 락토바실러스 브레비스 BMK484 균주와 락토바실러스 플란타륨 P1201 균주 각각 별도의 배양액으로서 첨가될 수도 있으며, 혼합 배양된 혼합 배양액으로서 첨가될 수도 있다.In the present invention, the complex spawn may be added as a separate culture solution for each of the Lactobacillus brevis BMK484 strain and the Lactobacillus plantarium P1201 strain, or may be added as a mixed culture solution mixed culture.
복합종균에서 상기 2종의 균주의 혼합 비율은 3 : 1 ~ 1 : 3(v/v)으로 혼합될 수 있다.In the complex seed, the mixing ratio of the two strains may be 3: 1 to 1: 3 (v/v).
발효는 상기 복합종균의 배양액을 증숙 및 숙성된 산양삼 또는 산양새싹삼에 2 ∼ 10% (v/w) 농도로 접종하여 25 ~ 40℃에서 2 ~ 7일간 발효시키는 것으로 수행될 수 있다.Fermentation may be performed by inoculating the culture broth of the complex seed into steamed and matured wild ginseng or wild wild ginseng at a concentration of 2 to 10% (v/w) and fermenting for 2 to 7 days at 25 to 40°C.
복합종균 접종량이 2%(v/w) 미만일 경우에는 발효 속도가 지연될 수 있고 10%(v/w) 초과 시에는 균체 증식 속도가 빨라 활성 진세노사이드의 전환율이 낮으며 신맛이 등이 과다할 수 있으며, 발효 온도가 25℃ 미만일 경우 발효기간이 길어져 잡균의 오염을 초래하고 40℃를 초과할 경우에는 균주의 생육이 정지될 수 있고, 발효 기간이 2일 미만일 경우 발효가 충분하지 않아 생리활성물질 등의 생성이 저조하게 될 수 있으며, 7일을 초과한 경우는 과발효에 의해 생리활성물질이 분해될 수 있다.If the inoculation amount of the complex seed is less than 2% (v/w), the fermentation rate may be delayed. If it exceeds 10% (v/w), the cell growth rate is high, so the conversion rate of active ginsenosides is low, and the sour taste is excessive. If the fermentation temperature is less than 25℃, the fermentation period is prolonged, causing contamination of various germs. If the fermentation temperature exceeds 40℃, the growth of the strain may be stopped. If the fermentation period is less than 2 days, fermentation is insufficient and menstruation The production of active substances, etc. may be poor, and if it exceeds 7 days, physiologically active substances may be decomposed by overfermentation.
또한 발효시, 필요에 따라서, 증숙 및 숙성된 산양삼 또는 산양새싹삼에 물을 첨가하여 수분이 40 ~ 50% (v/w)가 되도록 조정 및/또는 살균한 후, 복합종균을 접종하여 발효할 수 있다. 수분이 함량이 상기 범위일 때 발효 효율이 가장 높다. 40% 미만의 수분함량일 경우 미생물이 생존 혹은 생육을 위한 수분이 충분하지 않아 원활한 발효가 진행되지 않고 50% 초과의 경우 발효 종료 후 건조 시간과 비용이 많이 들 수 있으며, 살균 처리를 하지 않을 경우 잡균의 오염 등으로 원할한 발효가 진행되지 않을 수 있다.In addition, during fermentation, if necessary, water is added to steamed and aged wild ginseng or wild sprout ginseng to adjust and/or sterilize the moisture to 40-50% (v/w), and then inoculate complex seed to ferment. I can. Fermentation efficiency is highest when the moisture content is within the above range. If the moisture content is less than 40%, smooth fermentation does not proceed due to insufficient moisture for microorganisms to survive or grow, and if it exceeds 50%, drying time and cost may be high after fermentation is terminated, and if sterilization is not performed Smooth fermentation may not proceed due to contamination of various germs.
본 발명의 상기와 같은 단계로 가공되어 제조된 산양삼 숙성 복합발효물은, 가공 전에 비하여 진세노사이드 Rd2는 1.5배 이상, 진세노사이드 Rg3는 8.1배 이상, 진세노사이드 F2는 11.6배 이상, 진세노사이드 컴파운드 케이는 12.4배 이상 함량이 증진되었고, 페놀리스와 플라보노이드스의 함량도 각각 3.6배 이상 및 1.4배 이상 증진되었고, 오메가-6 지방산인 리놀레산과 아리키돈산은 각각 3.1배 이상 및 3.7배 이상 증진되었고, 가바는 3.1배 이상 증진되었다 (표 2, 도 2, 도 3a, 도 3b, 표 3).The fermented fermented wild mountain ginseng produced by the above steps of the present invention has 1.5 times more ginsenoside Rd2, 8.1 times more ginsenoside Rg3, 11.6 times more ginsenoside F2 than before processing, The content of senoside compound K was increased by more than 12.4 times, the contents of phenolis and flavonoids were also improved by more than 3.6 and 1.4 times, respectively, and the omega-6 fatty acids linoleic acid and arikidonic acid were improved by more than 3.1 and 3.7 times, respectively. It was enhanced, and Gaba was improved by more than 3.1 times (Table 2, Figure 2, Figure 3a, Figure 3b, Table 3).
본 발명의 또 다른 목적은 상기 제조방법에 의해 제조되고, 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 증진된 산양삼 숙성 복합발효물을 제공한다.Another object of the present invention is to prepare a complex fermented fermented mountain ginseng with improved ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids contents prepared by the above manufacturing method. to provide.
본 발명에 따른 산양삼 숙성 복합발효물은 진세노사이드 Rd2는 2.75 mg/g 이상, 진세노사이드 Rg3는 2.90 mg/g 이상, 진세노사이드 F2는 3.61 mg/g 이상, 진세노사이드 컴파운드 케이는 6.20 mg/g 이상 함유하고, 페놀릭스 8.48 mg/g 이상, 플라보노이드스 2.22 mg/g 이상 함유하고, 오메가-6 지방산인 리놀레산과 아리키돈산은 각각 282.6 mg/100g 이상 및 6.6 mg/100g 이상 함유하고, 가바는 100.33 mg/100g 이상 함유한다 (표 2, 도 2, 도 3a, 도 3b, 표 3). The complex fermented fermented fermented sanyangsam according to the present invention has ginsenoside Rd2 of 2.75 mg/g or more, ginsenoside Rg3 of 2.90 mg/g or more, ginsenoside F2 of 3.61 mg/g or more, and ginsenoside compound K of 6.20 mg/g or more, phenolics 8.48 mg/g or more, flavonoids 2.22 mg/g or more, and omega-6 fatty acids linoleic acid and arikidonic acid, respectively, containing 282.6 mg/100 g or more and 6.6 mg/100 g or more, Gaba contains 100.33 mg/100g or more (Table 2, Figure 2, Figure 3a, Figure 3b, Table 3).
본 발명에 따른 산양삼 숙성 복합발효물은 현저히 증진된 항산화 활성을 갖는다 (시험예 4). The complex fermented fermented mountain ginseng according to the present invention has a remarkably enhanced antioxidant activity (Test Example 4).
본 발명의 또 다른 목적에 따라서, 본 발명은 상기 제조방법에 의해 제조되고, 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 증진된 산양삼 숙성 복합발효물을 유효성분으로 포함하는 항산화 활성을 갖는 기능성식품을 제공한다.According to another object of the present invention, the present invention is prepared by the above production method, and the contents of ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids are enhanced. Provides functional foods with antioxidant activity, including aged complex fermented products as an active ingredient.
본 발명에서 기능성식품은 본 발명의 산양삼 숙성 복합발효물을 건조하여 분말화한 것을 그대로 이용하거나 혹은 추출하여 이용하거나, 식품첨가제로 사용하거나, 분말 혹은 추출액을 과립, 환, 음료, 젤리 등의 형태의 제품으로 제조될 수 있다.In the present invention, the functional food is dried and powdered of the fermented wild ginseng of the present invention as it is, or extracted and used as a food additive, or powder or extract in the form of granules, pills, beverages, jelly, etc. It can be manufactured as a product of
본 발명에 따른 식품은 면역력 저하 개선, 인지능력 개선, 피로회복 및 먹는 화장품(이너뷰티)으로 유용하다.The food according to the present invention is useful for improving immunity, improving cognitive ability, recovering from fatigue and eating cosmetics (inner beauty).
본 발명의 또 다른 목적에 따라서, 본 발명은 상기 제조방법에 의해 제조되고, 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스 및 플라보노이드스 함량이 증진된 산양삼 숙성 복합발효물을 유효성분으로 포함하는 항산화 활성을 갖는 화장품을 제공한다.According to another object of the present invention, the present invention is prepared by the above production method, and the contents of ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics and flavonoids are enhanced. Provides cosmetics with antioxidant activity containing complex fermented products as an active ingredient.
본 발명에 따른 화장품은 미백 및 주름개선용으로 유용하다.Cosmetics according to the present invention are useful for whitening and wrinkle improvement.
본 발명에 따른 산양삼 숙성 복합발표물은 건조하여 분말화한 것을 그대로 또는 추출하여 미백, 주름개선 혹은 보습을 위한 화장품의 첨가제로 이용하거나, 마스크팩, 스킨, 크림, 로션 등의 형태의 제품으로 제조될 수 있다.The fermented wild wild ginseng composite presentation according to the present invention is dried and powdered as it is or extracted and used as an additive in cosmetics for whitening, wrinkle improvement or moisturizing, or manufactured as a product in the form of a mask pack, skin, cream, lotion, etc. Can be.
본 발명의 제조방법은, 통상의 방법에 비하여, 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량과 항산화 활성이 현저히 증진된 산양삼 가공품을 생산케 한다. The production method of the present invention produces a processed wild ginseng product with significantly improved ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids content and antioxidant activity compared to conventional methods. Make it.
본 발명에 따른 산양삼 숙성 복합발효물은 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 현저히 증진되어 있고 더불어 항산화 효과도 우수하여, 기능성식품, 화장품 및 의약품의 소재로 사용될 수 있다. The complex fermented fermented sanyangsam according to the present invention has significantly improved ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids content, and also has excellent antioxidant effects. , It can be used as a material for cosmetics and pharmaceuticals.
본 발명에 따른 기능성식품은 우수한 항산화 활성을 가져서, 산화적 스트레스에 따른 면역력 저하 개선, 인지능력 개선, 피로회복, 먹는 화장품 및 피부 미용용으로 유용하다.Functional foods according to the present invention have excellent antioxidant activity, and are useful for improving immunity due to oxidative stress, improving cognitive ability, recovering from fatigue, eating cosmetics and skin care.
도 1은 본 발명에 따른 산양삼 숙성 복합발효물의 제조공정의 일례이다.1 is an example of a manufacturing process of a composite fermented fermented sanyangsam according to the present invention.
도 2은 본 발명에 따른 산양삼 숙성 복합발효물의 진세노사이드 화합물 HPLC 크로마토그램을 나타낸 것이다. 도 2a는 진세노사이드 표준물질 21종의 HPLC 크로마토그램이며, 도 2b는 비교예 1의 진세노사이드 화합물 HPLC 크로마토그램이며, 도 2c는 비교예 2의 진세노사이드 화합물 HPLC 크로마토그램이며, 도 2d는 실시예 1의 진세노사이드 화합물 HPLC 크로마토그램이며, 2e는 실시예 2의 진세노사이드 화합물 HPLC 크로마토그램이다. Figure 2 shows the ginsenoside compound HPLC chromatogram of the complex fermentation of sanyangsam according to the present invention. 2A is an HPLC chromatogram of 21 types of ginsenoside standards, FIG. 2B is an HPLC chromatogram of a ginsenoside compound of Comparative Example 1, and FIG. 2C is an HPLC chromatogram of a ginsenoside compound of Comparative Example 2, and FIG. 2D Is a ginsenoside compound HPLC chromatogram of Example 1, and 2e is a ginsenoside compound HPLC chromatogram of Example 2.
도 3은 본 발명에 따른 산양삼 숙성 복합발효물의 페놀릭스 및 플라보노이드스 함량을 나타낸 그래프이다. 도 3a는 총 페놀릭스 함량을 나타낸 것이며, 도 3b는 총 플라보노이드스 함량을 나타낸 것이다.Figure 3 is a graph showing the content of phenolics and flavonoids of fermented wild wild ginseng aging complex according to the present invention. Figure 3a shows the total phenolics content, Figure 3b shows the total flavonoids content.
도 4은 본 발명에 따른 산양삼 숙성 복합발효물의 항산화 활성을 나타낸 그래프이다. 도 4a는 DPPH 라디칼 소거활성을 나타낸 것이며, 도 4b는 ABTS 라디칼 소거활성을 나타낸 것이며, 도 4c는 히드록실 라디칼 소거활성을 나타낸 것이며, 도 4d는 FRAP 환원력을 나타낸 것이다.Figure 4 is a graph showing the antioxidant activity of the fermentation complex fermented sanyangsam according to the present invention. Figure 4a shows the DPPH radical scavenging activity, Figure 4b shows the ABTS radical scavenging activity, Figure 4c shows the hydroxyl radical scavenging activity, Figure 4d shows the FRAP reducing power.
다음의 실시예들에 의해 본 발명이 더 상세히 설명된다. 이들 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들에 의해 제한되어서는 안된다.The present invention is explained in more detail by the following examples. These examples are intended to illustrate the invention, and the scope of the invention should not be limited by them.
제조예Manufacturing example 1. One. 산양삼Sanyangsam 숙성 ferment 복합발효물Compound fermentation 제조 Produce
3년근 이상 산양삼(전초) 10 kg을 흐르는 물에 3회 세척하고 완전히 물기를 제거한 후, 5 kg을 찜기통에 담은 후 100℃에서 60분간 1차 증숙하였다. 1차 증숙된 산양삼을 밀폐형 숙성기에 각각 2 kg 담아 수분이 증발되게 하면서 75℃에서 1차 밀폐 숙성을 3일간 수행하였다. 1차 숙성된 산양삼에 수분(수분 함량 약 40%)을 첨가하고 찜기통에 담은 후 100℃에서 60분간 2차 증숙하였다. 2차 증숙된 산양삼을 개방형 숙성기에 옮겨 담은 후 65℃에서 3일간 2차 개방 숙성을 수행하였다. 2차 숙성된 산양삼에 수분(수분 함량 약 40%)을 첨가하고 찜기통에 담은 후 100℃에서 60분간 3차 증숙하였고, 3차 증숙된 산양삼을 다시 밀폐형 숙성기에 담고 75℃에서 3일간 3차 밀폐 숙성을 수행하였다. 최종적으로 3차 숙성된 산양삼에 수분(수분 함량 약 40%)을 첨가하고 찜기통에 담은 후 100℃에서 60분간 4차 중숙하고, 4차 증숙된 산양삼을 개방형 숙성기에 옮겨 담은 후 65℃에서 3일간 4차 개방 숙성을 수행하여 증숙 및 숙성된 산양삼을 제조하였다 (도 1). After washing 10 kg of wild ginseng (outpost) over 3 years old in running water 3 times and completely draining it, 5 kg was put in a steamer and then steamed for 60 minutes at 100°C. The first steamed wild ginseng was put in 2 kg each in a closed maturation machine, and the first sealed maturation was carried out at 75°C for 3 days while moisture was evaporated. Moisture (about 40% moisture content) was added to the first aged wild ginseng, put in a steamer, and then steamed for a second time at 100°C for 60 minutes. The second steamed wild ginseng was transferred to an open aging machine, and then the second open aging was performed at 65°C for 3 days. Water (about 40% moisture content) was added to the second-aged wild ginseng, and after being placed in a steamer, the third steamed for 60 minutes was performed at 100°C, and the third steamed wild ginseng was again placed in a sealed maturity for 3 days at 75°C. Sealed aging was performed. Finally, add moisture (about 40% of moisture content) to the third-aged wild ginseng, put it in a steamer, and cultivate for 4 times at 100°C for 60 minutes, and transfer the fourth steamed wild ginseng to an open-type maturation unit and place 3 at 65°C. Steamed and aged wild ginseng was prepared by performing 4 open aging for a day (Fig. 1).
제조된 증숙 및 숙성된 산양삼 500 g을 발효용기에 넣고 2배의 정세수(1 L)를 첨가하고 1시간동안 수화시켜 수분 함량을 약 50% 정도로 되게 조정한 후, 120℃에서 30분간 살균하고, 락토바실러스 플란타륨 P1201 균주 및 락토바실러스 브레비스 BMK484 균주를 각각 맥아엑기스 액체배지에서 종균으로 배양하며 1:1 비율로 혼합한 복합종균을 5% (v/w)로 접종하고 30℃에서 7일간 발효시켜 산양삼 숙성 복합발효물을 제조하였다 (실시예 1).Put 500 g of the prepared steamed and aged wild ginseng into a fermentation container, add twice as much clean water (1 L), and hydrate for 1 hour to adjust the moisture content to about 50%, then sterilize at 120°C for 30 minutes, Lactobacillus plantarium P1201 strain and Lactobacillus brevis BMK484 strain were each cultured as a seed in malt extract liquid medium, and a complex seed mixed at a ratio of 1:1 was inoculated at 5% (v/w) and fermented at 30°C for 7 days. To prepare a composite fermented fermented wild ginseng (Example 1).
한편 2년근 이상 산양삼의 묘삼을 30일 토경 재배한 산양새싹삼(전초) 10 kg을 상기와 동일한 방법으로 증숙, 숙성 및 복합발효한 산양삼(산양새싹삼) 숙성 발효조성물을 제조하였다 (실시예 2).On the other hand, 10 kg of goat sprout ginseng (outpost) grown on the soil for 30 days or longer of 2 years old wild ginseng was prepared by steaming, aging and complex fermentation of wild ginseng (goat sprout ginseng) aged fermentation composition (Example 2 ).
비교를 위하여, 원재료 산양삼을 비교예 1로서 준비하였고, 비교예 2로서 산양삼 5 kg을 100℃에서 1시간 증숙하고 건조 채반(개방형 용기)에 담은 후 65℃에서 3일간 건조시키는 공정을 4회 반복하여 12일간 숙성한 후 상기와 동일한 방법으로 발효한 산양삼 발효조성물을 준비하였다.For comparison, the raw material wild ginseng was prepared as Comparative Example 1, and as Comparative Example 2, 5 kg of wild ginseng was steamed at 100°C for 1 hour, placed in a dry tray (open container), and dried at 65°C for 3 days, and the process was repeated 4 times. Then, after aging for 12 days, a fermented sanyangsam fermentation composition fermented in the same manner as above was prepared.
<이화학적 특성><Physical and chemical properties>
실시예 1, 실시예 2, 비교예 1 및 2에 대해 이화학적 특성을 측정하였다. pH는 pH 미터기를 사용하여 측정하였고, 총산도는 중화적정법을 통해 수행하여 젖산으로 환산하여 표기하였고, 환원당은 DNS법(Mille, 1953)을 통해 수행하여 포도당으로 환산하여 표기하여 표 1에 나타내었다.Physicochemical properties were measured for Example 1, Example 2, and Comparative Examples 1 and 2. The pH was measured using a pH meter, and the total acidity was calculated in terms of lactic acid by performing the neutralization titration method, and the reducing sugar was performed through the DNS method (Mille, 1953) and converted into glucose. .
분석항목Analysis item 비교예 1Comparative Example 1 비교예 2Comparative Example 2 실시예 1Example 1 실시예 2Example 2
pHpH 5.055.05 4.214.21 4.314.31 4.264.26
산도 (%, 젖산기준)Acidity (%, based on lactic acid) 1.811.81 3.023.02 2.912.91 3.123.12
환원당 (mg/g)Reducing sugar (mg/g) 5.025.02 6.246.24 5.855.85 5.555.55
*모든 실험은 삼 반복 수행하여 평균값으로 나타냄*All experiments are repeated three times and expressed as an average value.
본 발명에 따라 제조된 산양삼 숙성 복합발효물(실시예 1과 실시예 2)는 비교예 1(원료산양삼)보다 pH는 감소하였고 총산도는 증가하여서, 보존성과 기호성이 향상된 것으로 판단된다. 환원당은 큰 차이는 없었다(표 1).It is judged that the fermented sanyangsam prepared in accordance with the present invention (Examples 1 and 2) had a lower pH and increased total acidity than Comparative Example 1 (raw sanyangsam), thereby improving preservation and palatability. There was no significant difference in reducing sugar (Table 1).
시험예Test example 1. 진세노사이드 함량 분석 1. Analysis of ginsenoside content
상기에서 제조된 실시예 1의 산양삼 숙성 복합발효물, 실시예 2의 산양새싹삼 숙성 복합발효물, 비교예 1의 원료 산양삼 및 비교예 2의 산양삼 발효조성물을 각각 50 ~ 55℃에서 2일 건조시킨 후 분쇄기로 100메쉬 이하로 분쇄하여 분말화하였다. The fermented fermented fermented fermented mountain ginseng of Example 1, the fermented fermented fermented fermented fermented mountain ginseng of Example 2, and the fermented fermentation composition of the raw material mountain ginseng of Comparative Example 1 and the fermented mountain ginseng of Comparative Example 2 were dried at 50 to 55°C for 2 days, respectively. After that, it was pulverized to 100 mesh or less with a grinder and powdered.
<분석시료 준비><Preparation of sample for analysis>
상기에서 제조된 분말은 건강기능식품분석법에 따라 삼 진세노사이드를 추출하였다. 구체적으로는 각 건조분말을 1 g씩 250 ㎖ 삼각플라스크에 정확히 취하고 70% 메탄올 20 ㎖를 가하여 80℃ 항온수조에서 1시간 정치한 후 냉각하였다. 이를 원심분리하여 상등액만 취하고 이를 2회 반복하였다. 이 상등액을 60℃에서 감압 농축하여 그 잔유물을 3차 증류수 2 ㎖에 용해하여 0.45 ㎛ 멤브레인 필터로 여과한 후 분석시료로 사용하였다.The powder prepared above was extracted from samginsenoside according to the health functional food analysis method. Specifically, 1 g of each dry powder was accurately taken in a 250 ml Erlenmeyer flask, 20 ml of 70% methanol was added, allowed to stand in a constant temperature water bath at 80° C. for 1 hour, and then cooled. This was centrifuged to take only the supernatant, and this was repeated twice. The supernatant was concentrated under reduced pressure at 60°C, the residue was dissolved in 2 ml of distilled water, filtered through a 0.45 μm membrane filter, and used as an analysis sample.
<진세노사이드 화합물 분석><Ginsenoside compound analysis>
진세노사이드 화합물 분석은 기능성식품 분석법에 기술된 방법을 변형하여 고압액체크로마토그래피(HPLC, high press liquid chromatograph)로 분석하였다. 분석 컬럼은 TSKgel ODS-100Z을 사용하여 시료주입량 10 ㎕, 온도는 30℃, 측정파장은 203 nm, 유속은 1.0 ㎖/min으로 하였고 이동상으로는 A용액은 HPLC water, B용액은 아세토니트릴을 사용하였다. HPLC 분석 조건은 이동상 용액은 0분때 A용액 81%:B용액 19%로 흘려주고, 15분때에는 A용액 80%:B용액 20%로 흘려주고, 40분때 A용액 77%:B용액 23%, 42분때 A용액 70%:B용액 30%, 75분때에 A용액 65%:B용액 35%, 80분때에 A용액30%:B용액70%, 90분때에 A용액 10%:B용액9 0%로 이동상을 흘려주었다. 분석된 비교예 1, 비교예 2, 실시예 1 및 실시예 2의 진세노사이드 함량은 표 2 및 도 2에 나타내었다. Ginsenoside compound analysis was performed by high press liquid chromatography (HPLC) by modifying the method described in the functional food analysis method. TSKgel ODS-100Z was used as the analysis column, and the sample injection amount was 10 μl, the temperature was 30°C, the measurement wavelength was 203 nm, and the flow rate was 1.0 ml/min. As the mobile phase, HPLC water was used for solution A and acetonitrile was used for solution B. . As for the HPLC analysis conditions, when the mobile phase solution was 0 minutes, flow A solution 81%: B solution 19%, 15 minutes, A solution 80%: B solution 20%, 40 minutes, A solution 77%: B solution 23%, Solution A 70%: Solution B 30% at 42 minutes, Solution A 65%: Solution B 35% at 75 minutes, Solution A 30% at 80 minutes: Solution B 70%, Solution A 10% at 90 minutes: Solution B 9 0 The mobile phase was shed in %. The analyzed ginsenoside content of Comparative Example 1, Comparative Example 2, Example 1, and Example 2 are shown in Table 2 and FIG. 2.
함량 (mg/g d.w.)Content (mg/g d.w.) 비교예 1Comparative Example 1 비교예 2Comparative Example 2 실시예 1Example 1 실시예 2Example 2
진세노사이드 Rd2Ginsenoside Rd2 1.811.81 2.772.77 2.752.75 4.634.63
진세노사이드 F2Ginsenoside F2 0.310.31 2.272.27 3.613.61 4.094.09
진세노사이드 Rg3Ginsenoside Rg3 0.360.36 1.931.93 3.033.03 2.902.90
진세노사이드 C.KGinsenoside C.K 0.500.50 4.134.13 6.206.20 6.306.30
*모든 실험은 삼 반복 수행하여 평균값으로 나타냄*All experiments are repeated three times and expressed as an average value.
표 2와 도 2에 나타낸 바와 같이, 실시예 1인 산양삼 숙성 복합발효물의 경우에는 비교예 1(원료 산양삼, 도 2b)에 비해, 진세노사이드 Rd2는 약 1.5배(2.75 mg/g) 이상, 진세노사이드 Rg3는 약 8.4배(3.03 mg/g) 이상, 진세노사이드 F2는 약 11.6배(3.61 mg/g) 이상과 진세노사이드 컴파운드 케이는 약 12.4배(6.20 mg/g) 이상으로 현저히 증진되었다(도 2d). 실시예 2의 산양새싹삼 숙성 복합발효물의 경우에는 진세노사이드 Rd2는 약 2.6배(4.63 mg/g) 이상, 진세노사이드 Rg3는 약 8.1배(2.90 mg/g) 이상 증진되었고, 특히 진세노사이드 F2는 약 13.2배(4.09 mg/g) 이상과 진세노사이드 컴파운드 케이는 약 12.6배(6.30 mg/g) 이상으로 현저히 증진되었다(도 2e). As shown in Table 2 and FIG. 2, in the case of the complex fermented fermented mountain ginseng of Example 1, compared to Comparative Example 1 (raw material mountain ginseng, FIG. 2b), ginsenoside Rd2 was about 1.5 times (2.75 mg/g) or more, Ginsenoside Rg3 is about 8.4 times (3.03 mg/g) or more, ginsenoside F2 is about 11.6 times (3.61 mg/g) or more, and ginsenoside compound K is about 12.4 times (6.20 mg/g) or more. Was enhanced (Fig. 2d). In the case of the complex fermentation of the fermented goat sprout ginseng of Example 2, ginsenoside Rd2 was increased by about 2.6 times (4.63 mg/g) or more, and ginsenoside Rg3 was improved by about 8.1 times (2.90 mg/g) or more, especially ginsenoside. Side F2 was significantly improved by about 13.2 times (4.09 mg/g) or more and ginsenoside compound K by about 12.6 times (6.30 mg/g) or more (Fig. 2e).
또한 실시예 1 및 2인 산양삼 혹은 산양새싹삼 숙성 복합발효물은 비교예 2의 산양삼 발효조성물에 비하여도 진세노사이드 Rg3, 진세노사이드 F2 및 컴파운드 케이는 훨씬 더 증진되었다. In addition, ginsenoside Rg3, ginsenoside F2, and compound K were much more improved compared to the fermented wild ginseng composition of Comparative Example 2.
시험예Test example 2. 2. 페놀릭스Phenolics And 플라보노이드스Flavonoids 함량 분석 Content analysis
생리활성성분인 페놀릭스와 플라보노이드스 함량을 분석하였다.The contents of phenolics and flavonoids, which are bioactive ingredients, were analyzed.
<분석시료 준비><Preparation of sample for analysis>
상기 시험예 1에서와 같이 준비된 각각의 분말 10 g에 50% 발효주정 10 ㎖를 첨가하여 상온(20±5℃)에서 24시간 추출하고 3,000 rpm의 속도로 원심분리 하여 상등액만을 취하여 추출물을 제조하고 이 추출물을 시료로 하여 총 페놀릭스와 총 플라보노이드스를 분석하였다. 10 ml of 50% fermented alcohol was added to 10 g of each powder prepared as in Test Example 1, extracted for 24 hours at room temperature (20±5° C.) and centrifuged at a speed of 3,000 rpm to prepare an extract by taking only the supernatant. Using this extract as a sample, total phenolics and total flavonoids were analyzed.
<총 페놀릭스 함량><Total phenolics content>
총 페놀릭스 함량은 Folin Denis법(1912)으로 측정하였다. Total phenolics content was measured by the Folin Denis method (1912).
구체적으로는 상기에서 준비된 각 분석시료를 시험관에 0.5 ㎖ 분주하고 여기에 25% Na 2CO 3 용액 0.5 ㎖를 첨가하여 3분간 정치시켰다. 다시 2N-Folin-Ciocalteu 페놀 시약 0.25 ㎖를 첨가하여 혼합한 다음 30℃에서 1시간 동안 정치시킨 후 750 nm에서 흡광도를 측정하였다. 이때 총 페놀릭스 함량은 갈산(Gallic acid)을 이용하여 작성한 표준곡선으로부터 함량을 구하여 갈산에 상당하는 양으로 계산하였고 그 결과를 도 3a에 나타냈다.Specifically, 0.5 ml of each analysis sample prepared above was dispensed into a test tube, 0.5 ml of a 25% Na 2 CO 3 solution was added thereto, and allowed to stand for 3 minutes. Again, 0.25 ml of 2N-Folin-Ciocalteu phenol reagent was added, mixed, and allowed to stand at 30° C. for 1 hour, and the absorbance was measured at 750 nm. At this time, the total phenolics content was calculated as an amount equivalent to gallic acid by obtaining the content from a standard curve prepared using gallic acid, and the results are shown in FIG. 3A.
도 3a에 나타낸 바와 같이, 총 페놀릭스 함량은 비교예 1(산양삼 원료)와 비교예 2(개방 숙성된 산양삼 발효조성물)에 비하여, 본 발명에 따른 산양삼 숙성 복합발효물(실시예 1)은 각각 약 3.6배와 1.5배 증진되었고, 산양새싹삼 숙성 복합발효물(실시예 2)은 각각 약 3.7배와 1.4배 증진되었다. As shown in Figure 3a, the total phenolics content was compared to Comparative Example 1 (wild ginseng raw material) and Comparative Example 2 (open-aged wild ginseng fermentation composition), the fermented wild wild ginseng complex fermentation according to the present invention (Example 1), respectively It was improved about 3.6 times and 1.5 times, and the complex fermentation of goat sprout ginseng (Example 2) was enhanced by about 3.7 times and 1.4 times, respectively.
<총 플라보노이드스 함량><Total flavonoid content>
총 플라보노이드스 함량은 Davis 변법으로 측정하였다. The total flavonoids content was determined by the Davis variant.
구체적으로는 상기에서 준비된 시료 0.1 ㎖에 1 N NaOH 0.01 ㎖를 첨가한 후 디에틸렌글리콜 1.0 ㎖를 첨가하여 37℃에서 1시간 방치 후 420 nm 흡광도를 측정하였다. 이때 총 플라보노이드스 함량은 루틴(rutin)의 최종 농도를 0, 0.25, 0.5, 1.0 mg/㎖로 제조하여 작성한 표준곡선으로부터 함량을 구하였고 그 결과는 도 3b에 나타내었다. Specifically, 0.01 ml of 1 N NaOH was added to 0.1 ml of the sample prepared above, 1.0 ml of diethylene glycol was added, and the mixture was allowed to stand at 37° C. for 1 hour, and the absorbance at 420 nm was measured. At this time, the total flavonoid content was obtained from a standard curve prepared by preparing the final concentration of rutin at 0, 0.25, 0.5, and 1.0 mg/ml, and the result is shown in FIG. 3B.
도 3b에 나타낸 바와 같이, 총 플라보노이드스 함량도, 비교예 1(산양삼 원료)와 비교예 2(개방 숙성된 산양삼 발효조성물)에 비하여, 본 발명에 따른 산양삼 숙성 복합발효물(실시예)은 각각 약 13.1배와 2.5배 증진되었고, 산양새싹삼 숙성 복합발효물(실시예 2)은 각각 약 13.2배와 2.6배 증진되었다. As shown in Figure 3b, the total flavonoids content, compared to Comparative Example 1 (wild ginseng raw material) and Comparative Example 2 (open ripened wild ginseng fermentation composition), the wild ginseng aged complex fermented product (Example) according to the present invention, respectively It was improved about 13.1 times and 2.5 times, and the complex fermentation of goat sprout ginseng maturation (Example 2) was improved about 13.2 times and 2.6 times, respectively.
시험예Test example 3. 오메가 6 지방산(리놀레산과 아라키돈산) 및 3. Omega 6 fatty acids (linoleic acid and arachidonic acid) and 가바Gaba 함량 분석 Content analysis
오메가 6 지방산 함량 분석은 가스 크로마토그래피(gas chromatograph, GC)로 분석하였고, 가바 함량 분석은 자동아미노산 분석기로 분석하였다.The content of omega 6 fatty acids was analyzed by gas chromatography (GC), and the content of Gaba was analyzed by an automatic amino acid analyzer.
<오메가 6 지방산 함량 분석><Omega 6 fatty acid content analysis>
식품공전법의 지방산 분석 방법에 준하여 수행하였다. It was carried out according to the fatty acid analysis method of the Food Code.
구체적으로는 상기 시험예 1에서와 같이 준비된 각각의 분말 1 g를 취하여 메탄올성 0.5 N NaOH 3 ㎖를 가하고 100℃에서 10분간 열처리 하였다. 그리고 나서 BF 3 2 ㎖를 가하여 교반한 후 다시 30분간 지방산 메틸화(methylation)를 수행하였다. 반응이 끝난 후 이소옥탄(isooctane) 1 ㎖를 첨가하여 혼합한 후 이소옥탄만을 회수하여 무수황산나트륨(sodium sulfite anhydrous)으로 탈수시킨 뒤 0.45 ㎛ 멤브레인 필터 (Dismic-25CS)로 여과하여 분석 시료로 사용하였다. Specifically, 1 g of each powder prepared as in Test Example 1 was taken, 3 ml of methanolic 0.5 N NaOH was added, and heat treatment was performed at 100°C for 10 minutes. Then, 2 ml of BF 3 was added and stirred, followed by methylation of fatty acids for 30 minutes. After the reaction was completed, 1 ml of isooctane was added and mixed, and only isooctane was recovered, dehydrated with sodium sulfite anhydrous, and filtered through a 0.45 μm membrane filter (Dismic-25CS) to be used as an analysis sample.
분석은 GC를 사용하였고 SP-2560 capillary column (100 m×0.25 mm, 0.20 ㎛, Sigma-Aldrich Co.)을 장착한 후 이동상은 질소 가스를 사용하였다. 상기 분석 시료 20 ㎕를 주입하여 1 ㎖/min의 이동상 속도를 유지하였다. 이때 오븐의 온도는 200℃까지 승온 후 최종 230℃에서 30분간 유지하여 형광 검출기를 사용하여 검출하여 그 함량을 표 3에 나타내었다.GC was used for analysis, and after mounting SP-2560 capillary column (100 m×0.25 mm, 0.20 µm, Sigma-Aldrich Co.), nitrogen gas was used as the mobile phase. 20 µl of the analysis sample was injected to maintain a mobile phase speed of 1 ml/min. At this time, the temperature of the oven was raised to 200°C and then maintained at 230°C for 30 minutes and detected using a fluorescence detector, and the content is shown in Table 3.
<가바 함량 분석><Gabar content analysis>
상기 시험예 1에서와 같이 준비된 각각의 산양삼 분말 1 g에 증류수 4 ㎖를 가해 60℃에서 1시간 가수분해시킨 후 10% 5-술포살리실산(sulfosalicylic acid) 1 ㎖를 첨가하여 4℃에서 2시간 방치시키고 원심분리하여 얻은 상등액을 0.45 μm 멤블레인 필터로 여과시켜 60℃에서 감압 농축하였다. 농축 후 건조물에 대하여 pH 2.2 리튬 버퍼(lithium buffer) 2 ㎖씩 첨가하여 용해 후 0.45 μm 멤블레인 필터로 여과시킨 것을 아미노산 자동분석기로 분석하여 그 함량을 표 3에 나타내었다.4 ml of distilled water was added to 1 g of each of the wild ginseng powder prepared as in Test Example 1, hydrolyzed at 60°C for 1 hour, and then 1 ml of 10% 5-sulfosalicylic acid was added and left at 4°C for 2 hours. Then, the supernatant obtained by centrifugation was filtered through a 0.45 μm membrane filter and concentrated under reduced pressure at 60°C. After concentration, 2 ml of a pH 2.2 lithium buffer was added to the dried product, dissolved and filtered through a 0.45 μm membrane filter, and analyzed by an automatic amino acid analyzer, and the contents are shown in Table 3.
함량 (mg/100 g d.w.)Content (mg/100 g d.w.) 비교예 1Comparative Example 1 비교예 2Comparative Example 2 실시예 1Example 1 실시예 2Example 2
리놀레산 (C18:2c)Linoleic acid (C18:2c) 261.6261.6 300.5300.5 329.1329.1 282.6282.6
아라키돈산 (C20:4n6)Arachidonic acid (C20:4n6) 1.81.8 4.34.3 7.47.4 6.66.6
가바 (GABA)GABA 75.12 75.12 83.17 83.17 100.61 100.61 100.33100.33
*모든 실험은 삼 반복 수행하여 평균값으로 나타냄*All experiments are repeated three times and expressed as an average value.
표 3에 나타낸 바와 같이, 비교예 1(산양삼 원료)에 비하여, 본 발명에 따른 산양삼 숙성 복합발효물(실시예 1)은 리놀레산과 가바가 각각 약 3.1배 (329.1 mg/100 g: 리놀레산 및 100.61 mg/100 g: 가바) 증진되었고, 특히 아리키돈산은 약 4.1배(7.4 mg/100 g)로 현저히 증진되었고, 산양새싹삼 숙성 복합발효물(실시예 2)은 리놀레산 함량(282.6 mg/100 g)은 증진되었으며, 가바와 아리키돈산은 각각 약 3.1배와 3.7배 증진되었다. 또한 비교예 2(개방 숙성된 산양삼 발효조성물)에 비하여도 본 발명에 따른 산양삼 숙성 복합발효물(실시예 1 및 2)은 아라키돈산과 가바가 훨씬 증진되었다. As shown in Table 3, compared to Comparative Example 1 (wild ginseng raw material), the fermented wild wild ginseng fermented product (Example 1) according to the present invention was about 3.1 times the amount of linoleic acid and gava, respectively (329.1 mg/100 g: linoleic acid and 100.61). mg/100 g: Gaba) was enhanced, and in particular, arikidonic acid was significantly improved to about 4.1 times (7.4 mg/100 g), and the complex fermented product (Example 2) aged goat sprout ginseng had linoleic acid content (282.6 mg/100 g) ) Was enhanced, and gaba and arikidonic acid were enhanced by about 3.1 and 3.7 times, respectively. In addition, compared to Comparative Example 2 (fermented composition of openly aged wild ginseng), the complex fermented product of fermented wild wild ginseng (Examples 1 and 2) according to the present invention showed much improved arachidonic acid and gaba.
시험예Test example 4. 항산화 활성 분석 4. Antioxidant activity assay
항산화 활성은 DPPH 라디칼 소거활성, ABTS 라디칼 소거활성, 히드록실(hydroxyl) 라디칼 소거활성 및 FRAP 환원력을 측정하여 분석하였다.Antioxidant activity was analyzed by measuring DPPH radical scavenging activity, ABTS radical scavenging activity, hydroxyl radical scavenging activity, and FRAP reducing power.
<시료 준비><Sample preparation>
상기 시험예 1에서와 같이 준비된 각각의 분말 10 g에 50% 발효주정 10 ㎖를 첨가하여 상온(20±5℃)에서 24시간 추출하고 3,000 rpm의 속도로 원심분리 하여 상등액만을 취하여 추출물을 제조하고, 각각의 추출물을 60℃에서 감압농축 및 동결건조 후, 0.25, 0.5, 1.0 mg/㎖ 농도로 제조한 시료를 대상으로 하여 항산화 활성 분석을 하였다.10 ml of 50% fermented alcohol was added to 10 g of each powder prepared as in Test Example 1, extracted for 24 hours at room temperature (20±5° C.) and centrifuged at a speed of 3,000 rpm to prepare an extract by taking only the supernatant. , Each extract was concentrated under reduced pressure at 60° C. and freeze-dried, followed by analysis of antioxidant activity on samples prepared at concentrations of 0.25, 0.5, and 1.0 mg/ml.
<DPPH 라디칼 소거활성><DPPH radical scavenging activity>
DPPH 라디칼 소거활성은 상기에서 준비된 시료 (0.25, 0.5, 1 mg/㎖ 농도) 0.2 ㎖에, DPPH 용액(1.5×10 -4 M) 0.8 ㎖를 첨가하여 균일하게 혼합한 30분간 방치한 후 525 nm에서 흡광도를 측정하여 수행하였다. DPPH 라디칼 소거활성의 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 수행하여 흡광도의 차이를 다음과 같은 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 4a에 도시하였다. DPPH radical scavenging activity was obtained by adding 0.8 ml of DPPH solution (1.5×10 -4 M) to 0.2 ml of the sample (0.25, 0.5, 1 mg/ml concentration) prepared above, uniformly mixing, and allowing to stand for 30 minutes and then 525 nm. It was carried out by measuring the absorbance at. The negative control of DPPH radical scavenging activity was performed in the same manner using distilled water instead of the sample, and the difference in absorbance was calculated as a percentage (%) by the following equation, and the result is shown in FIG. 4A.
라디칼 소거활성(%) = [1-(음성대조구 흡광도 ÷ 실험구 흡광도)]×100Radical scavenging activity (%) = [1-(absorbance of negative control ÷ absorbance of experimental sphere)]×100
<ABTS 라디칼 소거활성><ABTS radical scavenging activity>
ABTS 라디칼 소거활성은 7 mM ABTS 시약 5 ㎖과 140 mM K 2S 2O 8 (FW 270.3, Sigma 9392) 5 ㎖을 섞어 어두운 곳에 16시간 방치시켜 양이온 라디칼을 생성시킨 후, 이를 메탄올로 섞어 732 nm에서 대조구의 흡광도 값이 0.7±0.02가 되도록 조절한 ABTS 용액을 사용하였다. ABTS radical scavenging activity was obtained by mixing 5 ml of 7 mM ABTS reagent and 5 ml of 140 mM K 2 S 2 O 8 (FW 270.3, Sigma 9392) and standing in a dark place for 16 hours to generate cationic radicals, which were then mixed with methanol to 732 nm. In the ABTS solution adjusted so that the absorbance value of the control was 0.7±0.02 was used.
상기에서 준비된 시료 (0.25, 0.5, 1 mg/㎖ 농도) 0.1 ㎖과 ABTS 용액 0.9 ㎖를 혼합하여 3분간 반응시키고 732 nm에서 흡광도를 측정하였다. ABTS 라디칼 소거활성 역시 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 수행하여 흡광도의 차이를 상기 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 4b에 도시하였다. 0.1 ml of the sample prepared above (0.25, 0.5, 1 mg/ml concentration) and 0.9 ml of ABTS solution were mixed, reacted for 3 minutes, and absorbance was measured at 732 nm. The ABTS radical scavenging activity was also negative control was performed in the same manner using distilled water instead of the sample, and the difference in absorbance was calculated as a percentage (%) by the above equation, and the result is shown in FIG. 4B.
<히드록실 라디칼 소거활성><Hydroxy radical scavenging activity>
히드록실(·OH) 라디칼 소거능은 FeSO 4 .7H 20-EDTA (10 mM) 2㎖와 2-데옥시리보스 (10 mM) 0.2 ㎖, H 2O 2 (10 mM) 0.2 ㎖, 제조예의 각각의 조성물 1.4 ㎖를 혼합하고 37℃에서 4시간 반응시켜 이 혼합액에 1% 티오바비투르산(thiobarbituric acid, TBA)와 2.8% 트리클로로아세트산(trichloroaceric acid, TCA)를 각각 1 ㎖ 가하여 100℃에서 20분간 발색시켜 냉각시킨 후 520 nm에서 흡광도를 측정하여 행하였다. 히드록실 라디칼 소거활성도 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 수행하여 흡광도의 차이를 상기 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 4c에 나타내었다. The hydroxyl (·OH) radical scavenging ability is FeSO 4 . 7H 2 0-EDTA (10 mM) 2 ml and 2-deoxyribose (10 mM) 0.2 ml, H 2 O 2 (10 mM) 0.2 ml and 1.4 ml of each composition of Preparation Example were mixed and reacted at 37° C. for 4 hours, and 1% thiobarbituric acid (TBA) and 2.8% trichloroaceric acid (TCA) were added to the mixture. ) Was added to each of 1 ml, color was developed at 100°C for 20 minutes, cooled, and absorbance was measured at 520 nm. The negative control for hydroxyl radical scavenging activity was performed in the same manner using distilled water instead of the sample, and the difference in absorbance was calculated as a percentage (%) by the above equation, and the result is shown in FIG. 4C.
<FRAP 환원력 분석><FRAP reducing power analysis>
FRAP (Ferric reducing antioxidant power) 환원력 분석은 화합물의 환원력을 측정하는 방법으로 Fe 3 +를 Fe 2 +로 환원시키는 힘을 측정하는 방법이다. 구체적으로는 FeⅢ-TPTZ(ferric tripyridyl triazine)가 시료의 환원력에 의하여 푸른색의 FeⅡ-TPTZ(ferrous tripyridyl triazine)으로 환원될 때 흡광도를 측정하여 항산화 활성을 알아보는 것이다. FRAP (Ferric reducing antioxidant power) The reducing power analysis is a method of measuring the reducing power of a compound, and is a method of measuring the power to reduce Fe 3 + to Fe 2 + . Specifically, when FeIII-TPTZ (ferric tripyridyl triazine) is reduced to blue FeII-TPTZ (ferrous tripyridyl triazine) by the reducing power of the sample, the absorbance is measured to determine the antioxidant activity.
FRAP 환원력 분석에서 반응액으로는 30 mM 아세테이트 완충액(pH 3.6), 40 mM 염산에 녹인 10 mM 2,4,6-트리피리딜-s-트리아진(TPTZ, T1253, C 18H 12N 6, MW312.33) 및 20 mM FeCl 3(F7134, MW 162.20, in DW)를 준비하였으며, 아세테이트 완충액, TPTZ 용액 및 FeCl 3 용액을 10:1:1 (v/v/v)로 혼합하여 37℃에서 15분간 예비반응을 시켜두었다. In the FRAP reducing power analysis, the reaction solution was 30 mM acetate buffer (pH 3.6), 10 mM 2,4,6-tripyridyl-s-triazine dissolved in 40 mM hydrochloric acid (TPTZ, T1253, C 18 H 12 N 6 , MW312.33) and 20 mM FeCl 3 (F7134, MW 162.20, in DW) were prepared, and acetate buffer, TPTZ solution and FeCl 3 solution were mixed in 10:1:1 (v/v/v) at 37°C. It was allowed to pre-react for 15 minutes.
상기에서 준비된 각각의 분석시료(0.25, 0.5, 1 mg/㎖ 농도) 50 ㎕와 FRAP 시약 950 ㎕를 시험관에 분주한 후, 약 15분간 반응시키고 마이크로플레이트 리더 (Biorad 3055, Sweden)를 사용하여 593 nm에서 흡광도를 측정하여 그 결과를 도 4d에 나타냈다.50 µl of each of the assay samples (0.25, 0.5, 1 mg/ml concentration) prepared above and 950 µl of FRAP reagent were dispensed into a test tube, reacted for about 15 minutes, and 593 using a microplate reader (Biorad 3055, Sweden) The absorbance was measured at nm and the results are shown in FIG. 4D.
도 4a ~ 도 4d에 도시된 바와 같이, 비교예 1(산양삼 원료)와 비교예 2(개방 숙성된 산양삼 발효조성물)에 비하여, 본 발명에 따른 산양삼 숙성 복합발효물(실시예 1)과 산양새싹삼 숙성 발효복합물(실시예 2)은 DPPH 라디칼 소거활성, ABTS 라디칼 소거활성, 히드록실 라디칼 소거활성, FRAP 환원력이 모두 현저히 증진되었고, 특히 시료 1 mg/㎖ 처리시 실시예 1과 실시예 2의 DPPH 라디칼 소거활성은 각각 90.66%와 89.92%, ABTS 라디칼 소거활성은 각각 89.77%과 94.37%, 히드록실 라디칼 소거활성은 각각 64.57%과 67.72% 및 FRAP 환원력은 각각 1.752과 1.859로 매우 높게 나타났다.As shown in Figures 4a to 4d, compared to Comparative Example 1 (wild ginseng raw material) and Comparative Example 2 (open ripened wild ginseng fermentation composition), the fermented wild wild ginseng complex fermentation according to the present invention (Example 1) and goat sprouts The three-aged fermentation complex (Example 2) significantly improved DPPH radical scavenging activity, ABTS radical scavenging activity, hydroxyl radical scavenging activity, and FRAP reducing power. In particular, when treated with 1 mg/ml sample, the examples 1 and 2 were The DPPH radical scavenging activity was 90.66% and 89.92%, respectively, the ABTS radical scavenging activity was 89.77% and 94.37%, respectively, the hydroxyl radical scavenging activity was 64.57% and 67.72%, respectively, and the FRAP reducing power was very high at 1.752 and 1.859, respectively.
상기 결과들로부터, 본 발명에 따른 산양삼 또는 산양새싹삼 숙성 복합발효물은 항산화 활성도 현저히 증진되어 기능성식품 또는 화장품의 소재로 유용하다는 것을 알 수 있다.From the above results, it can be seen that the fermented fermented fermented sanyangsam or sanyang sprout ginseng according to the present invention remarkably enhances its antioxidant activity and thus is useful as a material for functional foods or cosmetics.
Figure PCTKR2019008889-appb-img-000001
Figure PCTKR2019008889-appb-img-000001
[규칙 제91조에 의한 정정 26.09.2019] 
Figure WO-DOC-FIGURE-15a
[Amendment 26.09.2019 under Rule 91]
Figure WO-DOC-FIGURE-15a
Figure WO-DOC-FIGURE-132

Figure WO-DOC-FIGURE-1322
Figure WO-DOC-FIGURE-132

Figure WO-DOC-FIGURE-1322

Claims (8)

  1. 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 증진된 산양삼 숙성 복합발효물의 제조방법으로,A method for producing a complex fermented fermented fermented mountain ginseng with improved ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids,
    상기 방법은 The above method is
    i) 산양삼 또는 산양새싹삼을 증숙 및 밀폐 숙성과 증숙 및 개방 숙성을 교대로 4회 수행하는 단계; 및 i) performing steaming and sealed ripening and steaming and open ripening of wild wild ginseng or wild mountain sprout ginseng alternately 4 times; And
    ii) 수탁번호 KACC 92157P로 기탁된 락토바실러스 브레비스 BMK484 균주와 수탁번호 KACC91848P로 기탁된 락토바실러스 플란타륨 P1201 균주의 복합 종균으로 발효하는 단계를 포함하고, ii) fermenting with a complex seed of the Lactobacillus brevis BMK484 strain deposited with the accession number KACC 92157P and the Lactobacillus plantarium P1201 strain deposited with the accession number KACC91848P,
    상기 증숙은 100℃에서 30 ~ 120분간 수행하고, The steaming is performed at 100° C. for 30 to 120 minutes,
    상기 밀폐 숙성은 70∼80℃의 밀폐형 숙성기에서 2∼3일간 숙성을 수행하고,The sealed aging is performed for 2-3 days in a sealed aging machine at 70 to 80°C,
    상기 개방 숙성은 60∼70℃의 개방형 숙성기에서 2∼3일간 숙성을 수행하는 것인 제조방법.The open aging process is to perform aging for 2 to 3 days in an open maturation period of 60 to 70 ℃.
  2. 제 1항에 따른 방법에 의해 제조되고, 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 증진된 산양삼 숙성 복합발효물.It is prepared by the method according to claim 1, and ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and a fermented wild wild ginseng with enhanced content of flavonoids.
  3. 제 2항에 있어서, 상기 산양삼 숙성 복합발효물은 진세노사이드 Rd2를 2.75 mg/g 이상, 진세노사이드 Rg3는 2.90 mg/g 이상, 진세노사이드 F2는 3.61 mg/g 이상, 진세노사이드 컴파운드 케이는 6.20 mg/g이상 함유하고, 페놀릭스 8.48 mg/g 이상, 플라보노이드스 2.22 mg/g 이상 함유하고, 오메가-6 지방산인 리놀레산과 아리키돈산은 각각 282.6 mg/100g 이상 및 6.6 mg/100 g 이상 함유하고, 가바는 100.33 mg/100g 이상 함유하는 것 특징으로 하는 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 증진된 산양삼 숙성 복합발효물.The method of claim 2, wherein the fermented fermented wild ginseng is 2.75 mg/g or more of ginsenoside Rd2, 2.90 mg/g or more of ginsenoside Rg3, 3.61 mg/g or more of ginsenoside F2, ginsenoside compound K contains at least 6.20 mg/g, phenolics at least 8.48 mg/g, flavonoids at at least 2.22 mg/g, and omega-6 fatty acids linoleic acid and arikidonic acid at least 282.6 mg/100 g and 6.6 mg/100 g, respectively Ginsenosides Rd2, Rg3, F2 and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids, characterized by containing more than 100.33 mg/100g of gaba water.
  4. 제 2항에 있어서, 상기 산양삼 숙성 복합발효물은 증진된 항산화 활성을 갖는 것을 특징으로 하는 진세노사이드 Rd2, Rg3, F2 및 컴파운드 케이, 오메가-6 지방산, 가바, 페놀릭스, 및 플라보노이드스 함량이 증진된 산양삼 숙성 복합발효물.The content of ginsenosides Rd2, Rg3, F2, and compound K, omega-6 fatty acids, gaba, phenolics, and flavonoids according to claim 2, wherein the fermented wild ginseng aged complex has enhanced antioxidant activity. Enhanced fermented wild ginseng aged complex.
  5. 제 2항 내지 제 4항 중 어느 한 항에 따른 산양삼 숙성 복합발효물을 포함하는 식품. A food comprising the fermented wild ginseng aged complex according to any one of claims 2 to 4.
  6. 제 2항 내지 제 4항 중 어느 한 항에 따른 산양삼 숙성 복합발효물을 포함하는 화장품. Cosmetics comprising the fermented wild ginseng aged complex according to any one of claims 2 to 4.
  7. 제 5항에 있어서, 상기 식품은 면역력 저하 개선, 인지능력 개선, 피로회복 및 먹는 화장품(이너뷰티)용인 것인 식품.The food according to claim 5, wherein the food is for improving immunity, improving cognitive ability, recovering from fatigue and eating cosmetics (inner beauty).
  8. 제 6항에 있어서, 상기 화장품은 미백 및 주름개선용인 것인 화장품.The cosmetic according to claim 6, wherein the cosmetic is for whitening and wrinkle improvement.
PCT/KR2019/008889 2018-10-30 2019-07-18 Matured mixed fermentation product of wild-cultivated ginseng in which ginsenoside absorbable in human body and omega-6 fatty acid are increased, and preparation method therefor WO2020091192A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180131307A KR102094084B1 (en) 2018-10-30 2018-10-30 Aged and complex-fermented mountain-cultivated ginseng having increased ginsenosides of human body absorption type and omega-6 fatty acid, and preparation method thereof
KR10-2018-0131307 2018-10-30

Publications (2)

Publication Number Publication Date
WO2020091192A1 WO2020091192A1 (en) 2020-05-07
WO2020091192A9 true WO2020091192A9 (en) 2020-09-10

Family

ID=69958447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/008889 WO2020091192A1 (en) 2018-10-30 2019-07-18 Matured mixed fermentation product of wild-cultivated ginseng in which ginsenoside absorbable in human body and omega-6 fatty acid are increased, and preparation method therefor

Country Status (2)

Country Link
KR (1) KR102094084B1 (en)
WO (1) WO2020091192A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102464052B1 (en) * 2020-07-06 2022-11-07 경상국립대학교산학협력단 Composition of complex-fermented sprout ginseng having increased ginsenoside F2, Rg3, Rd2 and compound K, chlorogenic acid, coumaric acid, catechin and quercetin, and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100884252B1 (en) * 2007-07-18 2009-03-11 주식회사 엔유씨전자 Red Ginseng Fermented with Lactobacillus plantarum NUC-J1 KCCM10852P and Pruducing Method thereof
KR100866504B1 (en) * 2008-09-23 2008-11-11 주식회사 비티씨 Microorganisms for fermentation of red ginseng and food composition containing fermented red ginseng
KR101683478B1 (en) * 2014-12-22 2016-12-08 재단법인 전주농생명소재연구원 Method for producing fermented red ginseng with enhanced ginsenoside Rg3 content
KR101882468B1 (en) * 2016-06-03 2018-07-27 대구대학교 산학협력단 THE MANUFACTURING METHOD OF KOREAN PANAX GINSENG FERMENTATION SOLUTION HAVING INCREASING OF Rg3, Rh1 AND COMPOUND K CONTENT AND ANTIOXIDANT PROPERTIES BY ISOLATED LACTIC ACID BACTERIA
KR101980450B1 (en) * 2017-11-15 2019-05-20 경남과학기술대학교 산학협력단 Composition of active wild-cultivated ginseng having increased ginsenoside Rd and compound K, chlorgenic acid and quercetin, and preparation method thereof

Also Published As

Publication number Publication date
KR102094084B1 (en) 2020-03-26
WO2020091192A1 (en) 2020-05-07

Similar Documents

Publication Publication Date Title
KR101452770B1 (en) Cosmetic composition comprising lactobacillus fermented solution having anti-oxidation, whitening and anti-wrinkle effect
KR101482873B1 (en) Fermentation metabolite of Dendropanax morbiferus produced by liquid-state fermentation and manufacturaring process for the same
WO2018080139A1 (en) Cosmetic composition containing ginseng fruit fermented material obtained by fermentation using aureobasidium pullulans and lactic acid bacteria
KR20140063948A (en) Manufacturing method of fermented red ginseng extract with enhanced ginsenosides rg3 and antioxidant activity
WO2018070626A1 (en) Method for preparing dendropanax morbiferus lactic acid bacteria fermentation solution, and dendropanax morbiferus lactic acid bacteria fermentation solution prepared thereby
KR20220025679A (en) Method for producing fermented apple postbiotics with increased effective component content using lactic acid bacteria
WO2010131910A9 (en) Composition for improving blood circulation containing fermented tea, and pharmaceutical and health-food compositions comprising the same
KR101980450B1 (en) Composition of active wild-cultivated ginseng having increased ginsenoside Rd and compound K, chlorgenic acid and quercetin, and preparation method thereof
KR20220025680A (en) Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria
WO2020091192A9 (en) Matured mixed fermentation product of wild-cultivated ginseng in which ginsenoside absorbable in human body and omega-6 fatty acid are increased, and preparation method therefor
KR20200083710A (en) Composition containing an fermentation extract of zanthoxylum schinifolium as an active ingredient and its use
CN111235003B (en) Pomegranate composite health-care fruit vinegar and preparation method thereof
WO2015099236A1 (en) Enzyme-fermented gigantic black garlic using natural enzyme liquid and complex fermentation liquid of yeast and riboflavin and method for preparing same
KR20200012236A (en) Novel lactic acid bacteria and method of preparing fermented product having effect of anti-obesity and anti-diabets using the same
KR102464052B1 (en) Composition of complex-fermented sprout ginseng having increased ginsenoside F2, Rg3, Rd2 and compound K, chlorogenic acid, coumaric acid, catechin and quercetin, and preparation method thereof
KR102132537B1 (en) Platycodon grandiflorum Liquid composition for stick-type container having increased ginsenosides of human body absorption type, and preparation method thereof
KR20190030850A (en) Platycodon radix composition containing high protocatechuic acid, epicatechin, and oleic acid and enhanced inhibition activities of alpha-glucosidase and pancreatic lipase, and preparation method thereof
KR20220025678A (en) Method for producing fermented barley sprout postbiotics with increased effective component content using lactic acid bacteria
KR20170100965A (en) Manufacturing Method of Fermentation Liquor of Extract from Mulberry and White Ginsing
KR102033214B1 (en) Atopy-effective food additive by developing intestinal absorption, manufacturing method thereof, and food containing the same
KR20090124115A (en) Method for preparing the functional fermented jujube and it&#39;s product
KR101768817B1 (en) Food composition for anti-oxidation and inhanced immunity comprising chamomile flower extract short-term fermented by lactic acid bacteria and the method of preparation thereof
WO2019177226A1 (en) Natural fermented composition of pollen using glacial snow water and preparation method therefor
CN106880043A (en) A kind of olive ferment and preparation method thereof
KR102116046B1 (en) A composition for preventing or treating cognitive impairment comprising an omega3 fatty acid

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19878348

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19878348

Country of ref document: EP

Kind code of ref document: A1